Usages in wwPDB of concept: c_0060
nUsages: 3892; SSE string: EEEEHHEEEEHHEE
4hnp:A    (VAL32) to   (THR239)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:B    (GLY32) to   (ILE228)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:C    (THR29) to   (LEU222)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:D    (SER27) to   (ASN225)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:F    (THR31) to   (GLY229)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:G    (ILE31) to   (ALA229)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:H     (THR1) to   (ASN194)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:K     (THR1) to   (ASP192)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:O    (VAL32) to   (THR239)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:P    (GLY32) to   (ILE228)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:Q    (THR29) to   (LEU222)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:R    (SER27) to   (ASN225)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:U    (ILE31) to   (THR226)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:V     (THR1) to   (ASN194)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hnp:Y     (THR1) to   (ASP192)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4x6z:B    (VAL32) to   (SER240)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:C    (GLY33) to   (ILE229)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:D    (THR31) to   (LEU224)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:L     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:P    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:Q    (GLY33) to   (PRO232)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:R    (THR31) to   (LEU224)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:W     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4x6z:Z     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4hrc:A    (VAL32) to   (THR239)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:B    (THR33) to   (ILE228)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:D    (SER27) to   (ASN225)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:F    (THR31) to   (GLY229)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:G    (ILE31) to   (ALA229)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:H    (VAL12) to   (ASN194)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:K     (THR1) to   (ASP192)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:O    (VAL32) to   (THR239)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:P    (GLY32) to   (ILE228)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:Q    (THR29) to   (LEU222)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:R    (SER27) to   (ILE222)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:U    (ILE31) to   (ALA229)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrc:Y    (ILE12) to   (ASP192)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:A    (VAL32) to   (THR239)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:B    (GLY32) to   (ILE228)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:C    (THR29) to   (LEU222)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:D    (SER27) to   (ASN225)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:F    (THR31) to   (GLY229)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:G    (ILE31) to   (ALA229)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:H     (THR1) to   (ASN194)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:K     (THR1) to   (ASP192)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:O    (VAL32) to   (THR239)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:P    (GLY32) to   (ILE228)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:R    (SER27) to   (ILE222)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:T    (THR31) to   (GLY229)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:U    (ILE31) to   (THR226)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:V     (THR1) to   (ASN194)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4hrd:Y     (THR1) to   (ASP192)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:A    (VAL35) to   (THR225)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:B    (THR36) to   (ILE223)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:C    (THR35) to   (LEU224)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:D    (SER35) to   (ASN226)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:F    (THR35) to   (GLY226)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:G    (ASN34) to   (THR223)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:H     (THR1) to   (ASN195)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:K    (ILE12) to   (VAL192)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:O    (VAL35) to   (THR225)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:P    (THR36) to   (ILE223)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:Q    (THR35) to   (LEU224)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:R    (SER35) to   (ASN226)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:V     (THR1) to   (ASN195)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdi:Y    (ILE12) to   (ASP191)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:A    (VAL35) to   (THR225)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:B    (THR36) to   (ILE223)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:C    (THR35) to   (LEU224)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:D    (SER35) to   (ASN226)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:F    (THR35) to   (VAL224)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:H     (THR1) to   (ASN195)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:K     (THR1) to   (ASP191)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:O    (VAL35) to   (THR225)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:P    (GLY35) to   (ILE223)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:T    (THR35) to   (VAL224)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:U    (ILE35) to   (THR223)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:V     (THR1) to   (ASN195)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3sdk:Y     (THR1) to   (ASP191)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:A    (VAL35) to   (THR225)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:B    (GLY35) to   (ILE223)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:C    (THR35) to   (LEU224)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:D    (SER35) to   (ASP225)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:F    (THR35) to   (GLY226)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:H     (THR1) to   (ASN195)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:K     (THR1) to   (ASP191)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:O    (VAL35) to   (THR225)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:P    (GLY35) to   (ILE223)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:Q    (THR35) to   (LEU224)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:R    (SER35) to   (ASP225)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:T    (THR35) to   (GLY226)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:V     (THR1) to   (ASN195)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3shj:Y     (THR1) to   (ASP191)  PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10  |   UBIQUITIN, DRUG DEVELOPMENT, CANCER, IMMUNOLOGY, PROTEIN DEGRADATION, UNFOLDED PROTEIN SUBSTRATES, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:D    (SER27) to   (ASN225)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:F    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:G    (ASN30) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:R    (SER27) to   (ASN225)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4int:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:D    (SER27) to   (ASP224)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:F    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:R    (SER27) to   (ASP224)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:T    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inr:Y     (THR2) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:D    (SER27) to   (ASP224)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:F    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:R    (SER27) to   (ASP224)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:T    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4inu:Y     (THR2) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112  |   UPS, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, NTN HYDROLASE, NON- LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1pma:B    (VAL12) to   (LEU187)  PROTEASOME FROM THERMOPLASMA ACIDOPHILUM  |   PROTEASE, PROTEASOME, HYDROLASE 
1pma:P    (VAL12) to   (PRO188)  PROTEASOME FROM THERMOPLASMA ACIDOPHILUM  |   PROTEASE, PROTEASOME, HYDROLASE 
1pma:U    (VAL12) to   (PRO188)  PROTEASOME FROM THERMOPLASMA ACIDOPHILUM  |   PROTEASE, PROTEASOME, HYDROLASE 
1pma:W    (VAL12) to   (LEU187)  PROTEASOME FROM THERMOPLASMA ACIDOPHILUM  |   PROTEASE, PROTEASOME, HYDROLASE 
1pma:Y    (VAL12) to   (PRO188)  PROTEASOME FROM THERMOPLASMA ACIDOPHILUM  |   PROTEASE, PROTEASOME, HYDROLASE 
1pma:Z    (VAL12) to   (PRO188)  PROTEASOME FROM THERMOPLASMA ACIDOPHILUM  |   PROTEASE, PROTEASOME, HYDROLASE 
3gpj:A    (VAL35) to   (THR225)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:B    (GLY35) to   (ILE223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:C    (THR35) to   (LEU224)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:D    (THR36) to   (ASP225)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:F    (THR35) to   (GLY226)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:H     (THR1) to   (ASN195)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:K     (THR1) to   (ASP191)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:O    (VAL35) to   (THR225)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:P    (GLY35) to   (ILE223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:Q    (THR35) to   (LEU224)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:R    (THR36) to   (ASP225)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:T    (THR35) to   (GLY226)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:U    (ASN34) to   (THR223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:V     (THR1) to   (ASN195)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpj:Y     (THR1) to   (ASP191)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B  |   PROTEASOME, VIRULENCE, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:A    (VAL35) to   (THR225)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:B    (GLY35) to   (ILE223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:C    (THR35) to   (LEU224)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:D    (SER35) to   (ASP225)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:F    (THR35) to   (GLY226)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:H     (THR1) to   (ASN195)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:K     (THR1) to   (ASP191)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:O    (VAL35) to   (THR225)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:P    (GLY35) to   (ILE223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:Q    (THR35) to   (LEU224)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:R    (SER35) to   (ASP225)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:T    (THR35) to   (GLY226)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:V     (THR1) to   (ASN195)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3gpw:Y     (THR1) to   (ASP191)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND  |   PROTEASOME, UBIQUITIN, CANCER THERAPY, IMMUNOLOGY, TIME- DEPENDENT ELIMINATION OF A DEFINED LEAVING GROUP, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
4y69:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:F    (THR31) to   (VAL227)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y69:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:F    (THR31) to   (VAL227)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6a:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:F    (THR31) to   (VAL227)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6v:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y6z:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:F    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:T    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y6z:Y     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y70:Y     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:F    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:T    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y74:Y     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y77:Y     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y78:Y     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4j70:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:D    (SER27) to   (ASN225)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:F    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:G    (ASN30) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:O    (VAL32) to   (LYS237)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:R    (SER27) to   (ASN225)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:T    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:U    (ASN30) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4j70:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E  |   PROTEASOME, DRUG DISCOVERY, IRREVERSIBLE INHIBITION, BETA-LACTONE, NTN HYDROLASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y7w:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:F    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:T    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7w:Y     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:F    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:G    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:T    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:U    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7x:Y     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y7y:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:F    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:T    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y80:Y     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:G    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:U    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y81:Y     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:F    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:T    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y82:Y     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:D    (SER27) to   (ASN225)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:G    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:R    (SER27) to   (ASN225)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:U    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y84:Y     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(4,4-F2P)NLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:D    (SER27) to   (ASN225)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:G    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:R    (SER27) to   (ASN225)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:U    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8g:Y     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:D    (SER27) to   (ASN225)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:G    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:R    (SER27) to   (ASN225)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:U    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8h:Y     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8j:Y     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8l:Y     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:F    (THR31) to   (VAL227)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8m:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4y8n:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:F    (THR31) to   (VAL227)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8n:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:G    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:U    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8o:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:H     (VAL4) to   (ASN194)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:V     (VAL4) to   (ASN194)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8q:Y     (THR1) to   (VAL193)  YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
1q5r:A    (ARG28) to   (GLY225)  THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES  |   PROTEASOME ASSEMBLY, PRO-PEPTIDE, INTER-SUBUNIT CONTACTS, RHODOCOCCUS ERYTHROPOLIS, HYDROLASE 
1q5r:B    (ARG28) to   (GLY225)  THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES  |   PROTEASOME ASSEMBLY, PRO-PEPTIDE, INTER-SUBUNIT CONTACTS, RHODOCOCCUS ERYTHROPOLIS, HYDROLASE 
1q5r:C    (ARG28) to   (GLY225)  THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES  |   PROTEASOME ASSEMBLY, PRO-PEPTIDE, INTER-SUBUNIT CONTACTS, RHODOCOCCUS ERYTHROPOLIS, HYDROLASE 
1q5r:D    (ARG28) to   (GLY225)  THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES  |   PROTEASOME ASSEMBLY, PRO-PEPTIDE, INTER-SUBUNIT CONTACTS, RHODOCOCCUS ERYTHROPOLIS, HYDROLASE 
1q5r:E    (ARG28) to   (GLY225)  THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES  |   PROTEASOME ASSEMBLY, PRO-PEPTIDE, INTER-SUBUNIT CONTACTS, RHODOCOCCUS ERYTHROPOLIS, HYDROLASE 
1q5r:F    (ARG28) to   (GLY225)  THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES  |   PROTEASOME ASSEMBLY, PRO-PEPTIDE, INTER-SUBUNIT CONTACTS, RHODOCOCCUS ERYTHROPOLIS, HYDROLASE 
1q5r:G    (ARG28) to   (GLY225)  THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES  |   PROTEASOME ASSEMBLY, PRO-PEPTIDE, INTER-SUBUNIT CONTACTS, RHODOCOCCUS ERYTHROPOLIS, HYDROLASE 
4y8s:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8s:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8s:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8s:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8s:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8s:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8s:K    (ILE12) to   (VAL193)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8s:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8s:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8s:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8s:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8s:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8s:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8s:Y    (ILE12) to   (VAL193)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8t:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:F    (THR31) to   (VAL227)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y8u:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9y:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:F    (THR31) to   (VAL227)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9y:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-H116E MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4y9z:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4y9z:Y     (THR1) to   (VAL193)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:F    (THR31) to   (GLY229)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:G    (ILE31) to   (SER228)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:T    (THR31) to   (GLY229)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:U    (ILE31) to   (SER228)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya0:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya1:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:F    (THR31) to   (VAL227)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya1:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-H116N MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya2:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:K    (ILE12) to   (VAL193)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya2:Y    (ILE12) to   (VAL193)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:F    (THR31) to   (VAL227)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:G    (ILE31) to   (SER228)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:U    (ILE31) to   (SER228)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya3:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya4:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya4:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-H114D MUTANT  |   HYDROLASE, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ya7:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya7:Y     (THR1) to   (VAL193)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
4ya9:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
3h6f:U    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6i:A    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
3h6i:W    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1  |   BINDING SITES, OXAZOLIDIN-2-ONE, CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME 
4jsq:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:D    (SER27) to   (ASP224)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:F    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:G    (ASN30) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:R    (SER27) to   (ASP224)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:T    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:U    (ASN30) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsq:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:B    (THR33) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:D    (SER27) to   (ASP224)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:G    (ASN30) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:K    (ILE12) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:P    (THR33) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:R    (SER27) to   (ASP224)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:U    (ASN30) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jsu:Y    (ILE12) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:D    (SER27) to   (ASP224)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:F    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:G    (ASN30) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:R    (SER27) to   (ASP224)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:T    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:U    (ASN30) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4jt0:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A  |   UPS, PROTEASOME, DRUG DISCOVERY, NON-COVALENT REVERSIBLE INHIBITION, BIVALENCE, TMC-95A DERIVATIVES, NTN HYDROLASE, NON-LYSOSOMAL PROTEIN BREAKDOWN, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3hfa:D    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT  |   CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hfa:A    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT  |   CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hfa:B    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT  |   CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hfa:F    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT  |   CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hfa:I    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT  |   CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hfa:K    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT  |   CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hfa:M    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT  |   CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hfa:O    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT  |   CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hfa:Q    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT  |   CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hfa:S    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT  |   CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hfa:U    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT  |   CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hfa:W    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT  |   CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hfa:Y    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT  |   CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
3hfa:1    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT  |   CRYSTALLOGRAPHY, X-RAY, MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE, OPEN GATE, MUTANT, HYDROLASE, PROTEASOME 
1fnt:A    (ILE40) to   (THR235)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
1fnt:B    (VAL32) to   (SER240)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
1fnt:C    (GLY33) to   (LYS228)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
1fnt:D    (THR31) to   (LEU224)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
1fnt:L     (THR1) to   (ASP192)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
1fnt:P    (VAL32) to   (SER240)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
1fnt:Q    (GLY33) to   (LYS228)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
1fnt:R    (THR31) to   (LEU224)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
1fnt:Z     (THR1) to   (ASP192)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, PROTEASE, PROTEASOME ACTIVATOR, CELL ADHESION, INTERFERON INDUCTION, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
2f16:A    (VAL35) to   (THR225)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:B    (THR36) to   (ILE223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:C    (THR35) to   (LEU224)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:D    (SER35) to   (ILE223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:G    (ASN34) to   (THR223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:H     (THR1) to   (ASN195)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:K     (THR1) to   (VAL192)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:O    (VAL35) to   (THR225)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:P    (THR36) to   (ILE223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:Q    (THR35) to   (LEU224)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:R    (SER35) to   (ILE223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:U    (ASN34) to   (THR223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:V     (THR1) to   (ASN195)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
2f16:Y     (THR1) to   (VAL192)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB  |   BETA-SANDWICH FLANKED BY HELICES, COMPLEX STRUCTURE COVALENTLY BOUND TO THE SYNTHETIC INIHIBTOR BORTEZOMIB, HYDROLASE 
3un4:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:D    (THR28) to   (ASP224)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:F    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:G    (ASN30) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:R    (THR28) to   (ASP224)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:T    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:U    (ASN30) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un4:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE -HYDROLASE-INHIBITOR COMPLEX, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3un8:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:B    (ALA34) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:D    (SER27) to   (ASP224)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:F    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:G    (ASN30) to   (ALA229)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:R    (SER27) to   (ASP224)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:T    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:U    (ASN30) to   (ALA229)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
3un8:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBTIOR COMPLEX 
1g0u:A    (VAL35) to   (THR225)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:B    (ALA37) to   (ILE223)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:C    (THR35) to   (LEU224)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:D    (SER35) to   (ASN226)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:F    (THR35) to   (GLY226)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:H     (THR1) to   (ASN195)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:K     (THR1) to   (ASP191)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:O    (VAL35) to   (THR225)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:P    (GLY35) to   (ILE223)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:Q    (THR35) to   (LEU224)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:T    (THR35) to   (GLY226)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:U    (ASN34) to   (SER225)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:V     (THR1) to   (ASN195)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
1g0u:Y     (THR1) to   (ASP191)  A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE  |   PROTEASOME, UBIQUITIN, DEGRADATION, PROTEASE, NTN-HYDROLASE 
2fak:A    (VAL35) to   (THR225)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:B    (GLY35) to   (ILE223)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:C    (THR35) to   (LEU224)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:D    (SER35) to   (ASP225)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:F    (THR35) to   (GLY226)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:G    (ASN34) to   (THR223)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:H     (THR1) to   (ASN195)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:K     (THR1) to   (ASP191)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:O    (VAL35) to   (THR225)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:P    (GLY35) to   (ILE223)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:Q    (THR35) to   (LEU224)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:R    (SER35) to   (ASP225)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:T    (THR35) to   (GLY226)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:U    (ASN34) to   (THR223)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:V     (THR1) to   (ASN195)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
2fak:Y     (THR1) to   (ASP191)  CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME  |   PROTEASOME, UBIQUITIN, DRUG DESIGN, INHIBITOR, PROTEASE, HYDROLASE 
3une:A    (ALA32) to   (PRO222)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:B    (GLY32) to   (VAL227)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:C    (SER30) to   (LEU220)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:D    (SER35) to   (LYS231)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:G    (THR38) to   (GLU232)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:H    (ILE12) to   (PHE185)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:K     (THR1) to   (SER188)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:M     (THR9) to   (GLY201)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:P    (GLY32) to   (VAL227)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:R    (SER35) to   (THR230)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:U    (THR38) to   (GLU232)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:V    (ILE12) to   (LEU186)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:Y     (THR1) to   (SER188)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:a     (VAL6) to   (GLY201)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:c    (ALA32) to   (PRO222)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:d    (GLY32) to   (SER220)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:e    (THR31) to   (LEU220)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:f    (SER35) to   (PHE229)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:g    (SER33) to   (ASP226)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:i    (THR38) to   (GLU232)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:j    (ILE12) to   (LEU186)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:l     (MET1) to   (PHE196)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:m     (THR1) to   (SER188)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:q    (ALA32) to   (PRO222)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:r    (THR33) to   (VAL227)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:s    (SER30) to   (ASN221)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:t    (SER35) to   (THR230)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:w    (THR38) to   (GLU232)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:x    (ILE12) to   (LEU186)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3une:1     (THR1) to   (SER188)  MOUSE CONSTITUTIVE 20S PROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unf:A    (ALA32) to   (PRO222)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:B    (THR32) to   (VAL226)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:C    (THR30) to   (PRO221)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:D    (SER27) to   (PHE221)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:E    (SER30) to   (ASP223)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:G    (LEU36) to   (GLU231)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:H     (THR1) to   (ARG187)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:K     (THR1) to   (SER193)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:O    (ALA32) to   (PRO222)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:P    (THR32) to   (VAL226)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:Q    (THR30) to   (PRO221)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:R    (SER27) to   (PHE221)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:S    (SER30) to   (ASP223)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:U    (LEU36) to   (GLU231)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:V     (THR1) to   (ARG187)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unf:Y     (THR1) to   (SER193)  MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957  |   PROTEASOME, ANTIGEN PRESENTATION, DRUG DEVELOPMENT, PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:L    (PHE20) to   (GLU218)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4z1l:Z    (PHE20) to   (GLU218)  YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3  |   HYDROLASE, PROTEASOME, INHIBITOR, BINDING ANALYSIS, LEAD STRUCTURE MOTIF, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3unh:A    (ALA32) to   (PRO222)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:B    (THR32) to   (VAL226)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:C    (THR30) to   (LEU219)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:D    (SER27) to   (PHE221)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:E    (SER30) to   (ASP223)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:G    (LEU36) to   (GLU231)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:H    (VAL12) to   (ARG187)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:K     (THR1) to   (GLU188)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:O    (ALA32) to   (PRO222)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:P    (THR32) to   (VAL226)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:Q    (THR30) to   (LEU219)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:R    (SER27) to   (PHE221)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:S    (SER30) to   (ASP223)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:U    (LEU36) to   (GLU231)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
3unh:Y     (THR1) to   (GLU188)  MOUSE 20S IMMUNOPROTEASOME  |   20S PROTEASOME COMPRISES 28 SUBUNITS, PROTEASE, CYTOSOL, HYDROLASE 
1g65:A    (VAL35) to   (LYS223)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:B    (GLY35) to   (ILE223)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:C    (THR35) to   (LEU224)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:D    (SER35) to   (ASN226)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:F    (THR35) to   (GLY226)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:G    (ASN34) to   (THR223)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:H     (THR2) to   (ASN195)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:O    (VAL35) to   (LYS223)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:P    (GLY35) to   (ILE223)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:Q    (THR35) to   (LEU224)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:R    (SER35) to   (ASN226)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:T    (THR35) to   (GLY226)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:V     (THR2) to   (ASN195)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1g65:Y     (THR1) to   (ASP191)  CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHA,BETA-EPOXYKETONE PROTEASOME INHIBITORS  |   PROTEASOME, EPOXOMICIN, UBIQUITIN, NTN-HYDOLASE, PROTEASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1ryp:A    (ASN39) to   (THR235)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:B    (VAL32) to   (THR239)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:C    (ALA35) to   (ILE229)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:D    (THR31) to   (LEU224)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:E    (SER35) to   (ILE230)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:G    (THR34) to   (GLY232)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:I     (THR1) to   (ASN194)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:L     (THR1) to   (ASP192)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:O    (ASN39) to   (THR235)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:P    (VAL32) to   (THR239)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:Q    (GLY33) to   (ILE229)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:R    (THR31) to   (LEU224)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:S    (SER35) to   (ILE230)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:W     (THR1) to   (ASN194)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
1ryp:Z     (THR1) to   (ASP192)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION  |   MULTICATALYTIC PROTEINASE, 20S PROTEASOME, PROTEIN DEGRADATION, ANTIGEN PROCESSING, HYDROLASE, PROTEASE 
2fhg:A    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME  |   MULTI-PROTEIN, MULTI-SUBUNIT COMPLEX, PROTEASE, PROTEASOME, HYDROLASE 
2fhg:B    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME  |   MULTI-PROTEIN, MULTI-SUBUNIT COMPLEX, PROTEASE, PROTEASOME, HYDROLASE 
2fhg:D    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME  |   MULTI-PROTEIN, MULTI-SUBUNIT COMPLEX, PROTEASE, PROTEASOME, HYDROLASE 
2fhg:F    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME  |   MULTI-PROTEIN, MULTI-SUBUNIT COMPLEX, PROTEASE, PROTEASOME, HYDROLASE 
2fhg:I    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME  |   MULTI-PROTEIN, MULTI-SUBUNIT COMPLEX, PROTEASE, PROTEASOME, HYDROLASE 
2fhg:K    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME  |   MULTI-PROTEIN, MULTI-SUBUNIT COMPLEX, PROTEASE, PROTEASOME, HYDROLASE 
2fhg:M    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME  |   MULTI-PROTEIN, MULTI-SUBUNIT COMPLEX, PROTEASE, PROTEASOME, HYDROLASE 
2fhg:O    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME  |   MULTI-PROTEIN, MULTI-SUBUNIT COMPLEX, PROTEASE, PROTEASOME, HYDROLASE 
2fhg:Q    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME  |   MULTI-PROTEIN, MULTI-SUBUNIT COMPLEX, PROTEASE, PROTEASOME, HYDROLASE 
2fhg:S    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME  |   MULTI-PROTEIN, MULTI-SUBUNIT COMPLEX, PROTEASE, PROTEASOME, HYDROLASE 
2fhg:U    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME  |   MULTI-PROTEIN, MULTI-SUBUNIT COMPLEX, PROTEASE, PROTEASOME, HYDROLASE 
2fhg:W    (LYS28) to   (THR226)  CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME  |   MULTI-PROTEIN, MULTI-SUBUNIT COMPLEX, PROTEASE, PROTEASOME, HYDROLASE 
2fhg:Y    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME  |   MULTI-PROTEIN, MULTI-SUBUNIT COMPLEX, PROTEASE, PROTEASOME, HYDROLASE 
2fhg:1    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME  |   MULTI-PROTEIN, MULTI-SUBUNIT COMPLEX, PROTEASE, PROTEASOME, HYDROLASE 
3hye:A    (VAL35) to   (THR225)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:B    (THR36) to   (ILE223)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:C    (THR35) to   (LEU224)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:D    (SER35) to   (ASP225)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:F    (THR35) to   (GLY226)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:G    (ASN34) to   (THR223)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:H     (THR1) to   (ASN195)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:K     (THR1) to   (ASP191)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:O    (VAL35) to   (THR225)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:P    (THR36) to   (ILE223)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:Q    (THR35) to   (LEU224)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:R    (SER35) to   (ASP225)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:T    (THR35) to   (GLY226)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:U    (ASN34) to   (THR223)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:V     (THR1) to   (ASN195)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
3hye:Y     (THR1) to   (ASP191)  CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE  |   CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, PROTEASOME, THREONINE PROTEASE, ISOPEPTIDE BOND, UBL CONJUGATION, ZYMOGEN 
2gpl:A    (VAL35) to   (THR225)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:B    (GLY35) to   (ILE223)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:C    (THR35) to   (LEU224)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:D    (SER35) to   (ASP225)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:F    (THR35) to   (GLY226)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:G    (ASN34) to   (SER225)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:H     (THR1) to   (ASN195)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:K     (THR1) to   (ASP191)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:O    (VAL35) to   (THR225)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:P    (GLY35) to   (ILE223)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:Q    (THR35) to   (LEU224)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:R    (SER35) to   (ASP225)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:T    (THR35) to   (GLY226)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:U    (ASN34) to   (SER225)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:V     (THR1) to   (ASN195)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
2gpl:Y     (THR1) to   (ASP191)  TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS  |   PROTEASOMAL SUBUNIT FOLD REPRESENTS AN ANTIPARALLEL BETA- SHEET FLANKED BY HELICES; NTN-HYDROLASE 
3ipm:A    (SER35) to   (GLN226)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN  |   PROTEASOME, PROTEASOMAL ATPASE, PROTEIN DEGRADATION, AAA ATPASE, ELECTRON CRYOMICROSCOPY, HYDROLASE, PROTEASE, THREONINE PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
3ipm:B    (SER35) to   (GLN226)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN  |   PROTEASOME, PROTEASOMAL ATPASE, PROTEIN DEGRADATION, AAA ATPASE, ELECTRON CRYOMICROSCOPY, HYDROLASE, PROTEASE, THREONINE PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
3ipm:C    (SER35) to   (GLN226)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN  |   PROTEASOME, PROTEASOMAL ATPASE, PROTEIN DEGRADATION, AAA ATPASE, ELECTRON CRYOMICROSCOPY, HYDROLASE, PROTEASE, THREONINE PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
3ipm:D    (SER35) to   (GLN226)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN  |   PROTEASOME, PROTEASOMAL ATPASE, PROTEIN DEGRADATION, AAA ATPASE, ELECTRON CRYOMICROSCOPY, HYDROLASE, PROTEASE, THREONINE PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
3ipm:E    (SER35) to   (GLN226)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN  |   PROTEASOME, PROTEASOMAL ATPASE, PROTEIN DEGRADATION, AAA ATPASE, ELECTRON CRYOMICROSCOPY, HYDROLASE, PROTEASE, THREONINE PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
3ipm:F    (SER35) to   (GLN226)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN  |   PROTEASOME, PROTEASOMAL ATPASE, PROTEIN DEGRADATION, AAA ATPASE, ELECTRON CRYOMICROSCOPY, HYDROLASE, PROTEASE, THREONINE PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
3ipm:H     (THR1) to   (PRO188)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN  |   PROTEASOME, PROTEASOMAL ATPASE, PROTEIN DEGRADATION, AAA ATPASE, ELECTRON CRYOMICROSCOPY, HYDROLASE, PROTEASE, THREONINE PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
3ipm:I     (THR1) to   (PRO188)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN  |   PROTEASOME, PROTEASOMAL ATPASE, PROTEIN DEGRADATION, AAA ATPASE, ELECTRON CRYOMICROSCOPY, HYDROLASE, PROTEASE, THREONINE PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
3ipm:J     (THR1) to   (PRO188)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN  |   PROTEASOME, PROTEASOMAL ATPASE, PROTEIN DEGRADATION, AAA ATPASE, ELECTRON CRYOMICROSCOPY, HYDROLASE, PROTEASE, THREONINE PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
3ipm:K     (THR1) to   (PRO188)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN  |   PROTEASOME, PROTEASOMAL ATPASE, PROTEIN DEGRADATION, AAA ATPASE, ELECTRON CRYOMICROSCOPY, HYDROLASE, PROTEASE, THREONINE PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
3ipm:L     (THR1) to   (PRO188)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN  |   PROTEASOME, PROTEASOMAL ATPASE, PROTEIN DEGRADATION, AAA ATPASE, ELECTRON CRYOMICROSCOPY, HYDROLASE, PROTEASE, THREONINE PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
3ipm:M     (THR1) to   (PRO188)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN  |   PROTEASOME, PROTEASOMAL ATPASE, PROTEIN DEGRADATION, AAA ATPASE, ELECTRON CRYOMICROSCOPY, HYDROLASE, PROTEASE, THREONINE PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
3ipm:N     (THR1) to   (PRO188)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN  |   PROTEASOME, PROTEASOMAL ATPASE, PROTEIN DEGRADATION, AAA ATPASE, ELECTRON CRYOMICROSCOPY, HYDROLASE, PROTEASE, THREONINE PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
2h6j:G    (ARG28) to   (GLY225)  CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)  |   20S PROTEASOME, HALF PROTEASOME, ASSEMBLY-DEPENDENT ACTIVATION, HYDROLASE 
4zzg:A    (ILE40) to   (LEU236)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:B    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:D    (THR31) to   (LEU224)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:L     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:P    (VAL32) to   (LYS237)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:Q    (GLY33) to   (ILE229)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:R    (THR31) to   (LEU224)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:S    (SER35) to   (ASN233)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4zzg:Z     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR  |   20S PROTEASOME, LOW-MOLECULAR MASS ACTIVATORS, ALLOSTERIC REGULATION, HYDROLASE 
4lqi:A    (VAL35) to   (LYS223)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:B    (GLY35) to   (ILE223)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:C    (THR35) to   (LEU224)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:D    (SER35) to   (ASP225)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:H     (THR1) to   (ASN195)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:K     (THR1) to   (ASP191)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:O    (VAL35) to   (LYS223)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:P    (GLY35) to   (ILE223)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:Q    (THR35) to   (LEU224)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:R    (SER35) to   (ASP225)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:V     (THR1) to   (ASN195)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4lqi:Y     (THR1) to   (ASP191)  YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE  |   BETA-LACTONE, INHIBITOR, NATURAL PRODUCT, TARGET IDENTIFICATION, NTN- PROTEASE, CELLULAR PROTEIN DEGRADATION, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:A    (VAL32) to   (THR239)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:B    (GLY32) to   (ILE228)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:C    (THR29) to   (LEU222)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:D    (SER27) to   (ILE222)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:F    (THR31) to   (GLY229)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:G    (ASN30) to   (THR226)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:O    (VAL32) to   (THR239)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:P    (GLY32) to   (ILE228)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:Q    (THR29) to   (LEU222)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:R    (SER27) to   (ILE222)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:T    (THR31) to   (GLY229)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:U    (ASN30) to   (THR226)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:H     (THR1) to   (ASN194)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:K     (THR1) to   (ASP192)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:V     (THR1) to   (ASN194)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4ltc:Y    (ILE12) to   (ASP192)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6  |   PROTEASOME, INHIBITOR, CARMAPHYCIN, EPOXYKETONE, VINYLKETONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
1iru:A    (LEU37) to   (THR231)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:B    (ALA32) to   (PRO222)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:C    (GLY32) to   (ARG226)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:E    (SER35) to   (PHE229)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:I    (ILE12) to   (ARG187)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:K     (MET1) to   (ASP192)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:N     (THR9) to   (GLU200)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:O    (LEU37) to   (THR231)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:P    (ALA32) to   (PRO222)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:Q    (GLY32) to   (ARG226)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:S    (SER35) to   (PHE229)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:W    (ILE12) to   (ARG187)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:Y     (MET1) to   (ASP192)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:Z    (VAL12) to   (ASN191)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
1iru:2     (THR9) to   (GLU200)  CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION  |   20S PROTEASOME, CELL CYCLE, IMMUNE RESPONSE, PROTEOLYSIS, UBIQUITIN, HYDROLASE 
5ahj:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
5ahj:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A  |   HYDROLASE, PROTEASOME, NATURAL PRODUCT, TARGET IDENTIFICATION, INHIBITION, BINDING ANALYSIS 
1j2p:A    (THR36) to   (GLU223)  ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS  |   PROTEASOME, ALPHA-RING, HYDROLASE 
1j2p:B    (THR36) to   (GLU223)  ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS  |   PROTEASOME, ALPHA-RING, HYDROLASE 
1j2p:C    (THR36) to   (GLU223)  ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS  |   PROTEASOME, ALPHA-RING, HYDROLASE 
1j2p:D    (THR36) to   (GLU223)  ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS  |   PROTEASOME, ALPHA-RING, HYDROLASE 
1j2p:E    (THR36) to   (GLU223)  ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS  |   PROTEASOME, ALPHA-RING, HYDROLASE 
1j2p:F    (THR36) to   (GLU223)  ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS  |   PROTEASOME, ALPHA-RING, HYDROLASE 
1j2p:G    (THR36) to   (GLU223)  ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS  |   PROTEASOME, ALPHA-RING, HYDROLASE 
1j2q:A    (ALA35) to   (SER225)  20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS  |   PROTEASOME, UBIQUITIN, 20S, CP, HYDROLASE 
1j2q:B    (ALA35) to   (GLU223)  20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS  |   PROTEASOME, UBIQUITIN, 20S, CP, HYDROLASE 
1j2q:C    (ALA35) to   (SER225)  20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS  |   PROTEASOME, UBIQUITIN, 20S, CP, HYDROLASE 
1j2q:D    (ALA35) to   (GLU223)  20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS  |   PROTEASOME, UBIQUITIN, 20S, CP, HYDROLASE 
1j2q:E    (ALA35) to   (GLU223)  20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS  |   PROTEASOME, UBIQUITIN, 20S, CP, HYDROLASE 
1j2q:F    (ALA35) to   (SER225)  20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS  |   PROTEASOME, UBIQUITIN, 20S, CP, HYDROLASE 
1j2q:G    (ALA35) to   (SER225)  20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS  |   PROTEASOME, UBIQUITIN, 20S, CP, HYDROLASE 
1j2q:H     (THR1) to   (PRO188)  20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS  |   PROTEASOME, UBIQUITIN, 20S, CP, HYDROLASE 
1j2q:I     (THR1) to   (PRO188)  20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS  |   PROTEASOME, UBIQUITIN, 20S, CP, HYDROLASE 
1j2q:J     (THR1) to   (PRO188)  20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS  |   PROTEASOME, UBIQUITIN, 20S, CP, HYDROLASE 
1j2q:K     (THR1) to   (PRO188)  20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS  |   PROTEASOME, UBIQUITIN, 20S, CP, HYDROLASE 
1j2q:L     (THR1) to   (PRO188)  20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS  |   PROTEASOME, UBIQUITIN, 20S, CP, HYDROLASE 
1j2q:M     (THR1) to   (PRO188)  20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS  |   PROTEASOME, UBIQUITIN, 20S, CP, HYDROLASE 
1j2q:N     (THR1) to   (PRO188)  20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS  |   PROTEASOME, UBIQUITIN, 20S, CP, HYDROLASE 
1jd2:A    (VAL35) to   (LYS223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:B    (GLY35) to   (ILE223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:C    (THR35) to   (LEU224)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:D    (SER35) to   (ASN226)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:F    (THR35) to   (GLY226)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:G    (ASN34) to   (THR223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:H     (THR1) to   (ASN195)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:K     (THR1) to   (ASP191)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:O     (THR1) to   (ASN195)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:R     (THR1) to   (ASP191)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:V    (VAL35) to   (LYS223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:W    (GLY35) to   (ILE223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:Y    (SER35) to   (ILE223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:1    (THR35) to   (GLY226)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
1jd2:2    (ASN34) to   (THR223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR  |   BETA-SANDWICH, PROTEASOME:INHIBITOR COMPLEX, HYDROLASE, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
3wxr:A    (ASN39) to   (ALA238)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3wxr:B    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3wxr:C    (GLY33) to   (ILE229)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3wxr:I     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3wxr:L     (THR1) to   (ASP192)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3wxr:O    (ASN39) to   (ALA238)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3wxr:P    (VAL32) to   (SER240)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3wxr:Q    (GLY33) to   (ILE229)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3wxr:S    (SER35) to   (ASP232)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3wxr:U    (THR34) to   (VAL230)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3wxr:W     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3wxr:Z     (THR1) to   (ASP192)  YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT  |   UPS, 20S PROTEASOME, HYDROLASE, PROTEASE, 19S REGULATORY PARTICLE, MULTICATALYTIC PROTEASE 
3j9i:S    (SER35) to   (GLN226)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:Z     (THR1) to   (THR189)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:F    (SER35) to   (GLN226)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:M     (THR1) to   (THR189)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:T    (SER35) to   (GLN226)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:1     (THR1) to   (THR189)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:G    (SER35) to   (GLN226)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:N     (THR1) to   (THR189)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:U    (SER35) to   (GLN226)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:2     (THR1) to   (THR189)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:A    (SER35) to   (GLN226)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:H     (THR1) to   (THR189)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:O    (SER35) to   (GLN226)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:V     (THR1) to   (THR189)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:B    (SER35) to   (GLN226)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:I     (THR1) to   (THR189)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:P    (SER35) to   (GLN226)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:W     (THR1) to   (THR189)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:C    (SER35) to   (GLN226)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:J     (THR1) to   (THR189)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:Q    (SER35) to   (GLN226)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:X     (THR1) to   (THR189)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:D    (SER35) to   (GLN226)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:K     (THR1) to   (THR189)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:R    (SER35) to   (GLN226)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:Y     (THR1) to   (THR189)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:E    (SER35) to   (GLN226)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
3j9i:L     (THR1) to   (THR189)  THERMOPLASMA ACIDOPHILUM 20S PROTEASOME  |   PROTEASOME, HYDROLASE 
4nnn:A    (VAL32) to   (THR239)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:B    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:C    (THR29) to   (LEU222)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:D    (SER27) to   (ILE222)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:G    (ILE31) to   (THR226)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:H    (VAL12) to   (ASN194)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:K     (THR1) to   (VAL193)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:O    (VAL32) to   (THR239)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:P    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:Q    (THR29) to   (LEU222)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:R    (SER27) to   (ILE222)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:U    (ILE31) to   (THR226)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:V    (VAL12) to   (ASN194)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnn:Y     (THR1) to   (VAL193)  YCP IN COMPLEX WITH MG132  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, ALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:A    (VAL32) to   (THR239)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:B    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:C    (THR29) to   (LEU222)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:D    (SER27) to   (ASN225)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:G    (ASN30) to   (THR226)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:H    (VAL12) to   (ASN194)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:K     (THR1) to   (VAL193)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:O    (VAL32) to   (THR239)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:P    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:Q    (THR29) to   (LEU222)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:R    (SER27) to   (ASN225)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:U    (ASN30) to   (THR226)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:V    (VAL12) to   (ASN194)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4nnw:Y     (THR1) to   (VAL193)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOALDEHYDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:A    (VAL32) to   (THR239)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:B    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:C    (THR29) to   (LEU222)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:D    (SER27) to   (ILE222)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:G    (ILE31) to   (THR226)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:H    (VAL12) to   (ASN194)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:K     (THR1) to   (ASP192)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:O    (VAL32) to   (THR239)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:P    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:Q    (THR29) to   (LEU222)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:R    (SER27) to   (ILE222)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:U    (ILE31) to   (THR226)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:V    (VAL12) to   (ASN194)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no1:Y     (THR1) to   (ASP192)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, BORONIC ACID, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:A    (VAL32) to   (THR239)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:B    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:C    (THR29) to   (LEU222)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:D    (SER27) to   (ILE222)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:G    (ILE31) to   (THR226)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:H     (THR1) to   (ASN194)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:K     (THR1) to   (VAL193)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:N     (THR1) to   (TYR189)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:O    (VAL32) to   (THR239)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:P    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:Q    (THR29) to   (LEU222)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:R    (SER27) to   (ILE222)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:U    (ILE31) to   (THR226)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:V     (THR1) to   (ASN194)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:Y     (THR1) to   (VAL193)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no6:b     (THR1) to   (TYR189)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, IRREVERSIBLE INHIBITOR, VINYLSULFONE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:A    (VAL32) to   (THR239)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:B    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:C    (THR29) to   (LEU222)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:D    (SER27) to   (ILE222)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:G    (ILE31) to   (THR226)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:H     (THR1) to   (ASN194)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:K     (THR1) to   (ASP192)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:O    (VAL32) to   (THR239)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:P    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:Q    (THR29) to   (LEU222)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:R    (SER27) to   (ILE222)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:U    (ILE31) to   (THR226)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:V     (THR1) to   (ASN194)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4no8:Y     (THR1) to   (ASP192)  YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE  |   PROTEASOME, PEPTIDE ELECTROPHILE, BINDING ANALYSIS, REVERSIBLE INHIBITOR, KETOAMIDE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3jse:A    (SER35) to   (TYR224)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jse:C    (SER35) to   (TYR224)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jse:D    (SER35) to   (TYR224)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jse:G    (SER35) to   (TYR224)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, PROTEASOME ACTIVATION, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE, HYDROLASE/HYDROLASE ACTIVATOR COMPLEX 
3jtl:A    (SER35) to   (TYR224)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3jtl:B    (SER35) to   (TYR224)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3jtl:C    (SER35) to   (TYR224)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3jtl:D    (SER35) to   (TYR224)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3jtl:E    (SER35) to   (TYR224)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3jtl:F    (SER35) to   (TYR224)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3jtl:G    (SER35) to   (TYR224)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3jtl:J    (VAL12) to   (THR189)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3jtl:K    (VAL12) to   (THR189)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
3jtl:L    (VAL12) to   (THR189)  CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR  |   20S PROTEASOME, PA26, CYTOPLASM, HYDROLASE, PROTEASE, PROTEASOME, THREONINE PROTEASE 
5cgg:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:G    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:U    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgg:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:G    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:U    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgh:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cgi:Y     (THR1) to   (VAL193)  YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
2z5c:C    (SER35) to   (ASN233)  CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY  |   PROTEASOME, CHAPERONE, S. CEREVISIAE, CHAPERONE/HYDROLASE COMPLEX 
2z5c:F    (SER35) to   (ASN233)  CRYSTAL STRUCTURE OF A NOVEL CHAPERONE COMPLEX FOR YEAST 20S PROTEASOME ASSEMBLY  |   PROTEASOME, CHAPERONE, S. CEREVISIAE, CHAPERONE/HYDROLASE COMPLEX 
2zcy:A    (VAL35) to   (THR225)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:B    (GLY35) to   (ILE223)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:C    (THR35) to   (LEU224)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:D    (SER35) to   (ASP225)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:G    (ASN34) to   (THR223)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:H     (THR1) to   (ASN195)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:K     (THR1) to   (VAL192)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:O    (VAL35) to   (THR225)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:P    (GLY35) to   (ILE223)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:Q    (THR35) to   (LEU224)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:R    (SER35) to   (ASP225)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:U    (ASN34) to   (THR223)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:V     (THR1) to   (ASN195)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
2zcy:Y     (THR1) to   (VAL192)  YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX  |   ALPHA/BETA SANDWICH, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
5cz6:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:F    (THR31) to   (VAL227)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:K     (ALA1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz6:Y     (ALA1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A, PROPEPTIDE EXPRESSED IN TRANS  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:G    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:U    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cz5:Y    (ILE12) to   (VAL193)  YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5cza:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:F    (THR31) to   (VAL227)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5cza:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-D166N MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0s:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:B    (THR33) to   (ILE228)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:P    (THR33) to   (ILE228)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0s:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:B    (THR33) to   (ILE228)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:K    (ILE12) to   (ASP192)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:P    (THR33) to   (ILE228)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0t:Y    (ILE12) to   (ASP192)  YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:G    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:K    (ILE12) to   (ASP192)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:U    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0v:Y     (CYS1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0w:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:K     (SER1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0w:Y     (SER1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-T1S MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5d0x:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:F    (THR31) to   (GLY229)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:K     (SER1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:T    (THR31) to   (GLY229)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0x:Y     (SER1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:G    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:K     (SER1) to   (VAL193)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:U    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5d0z:Y     (SER1) to   (VAL193)  YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
1ya7:B    (SER35) to   (TYR224)  IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX  |   ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1ya7:C    (SER35) to   (TYR224)  IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX  |   ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1ya7:D    (SER35) to   (TYR224)  IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX  |   ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1ya7:E    (SER35) to   (GLN226)  IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX  |   ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1ya7:F    (SER35) to   (GLN226)  IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX  |   ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1ya7:G    (SER35) to   (TYR224)  IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX  |   ARCHAEAL PROTEASOME, PA26, COPMLEX, OPEN GATE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1yau:C    (SER35) to   (TYR224)  STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX  |   PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1yau:D    (SER35) to   (TYR224)  STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX  |   PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1yau:E    (SER35) to   (GLN226)  STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX  |   PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1yau:F    (SER35) to   (GLN226)  STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX  |   PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1yau:G    (SER35) to   (GLN226)  STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX  |   PROTEASOME 20S, PA26 PROTEASOME ACTIVATOR 11S, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
3krd:A    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B  |   BINDING SITES, MYCOBACTERIUM TUBERCULOSIS, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME, FELLUTAMIDE B, INHIBITION, PROTEASE, THREONINE PROTEASE, VIRULENCE, AUTOCATALYTIC CLEAVAGE, ZYMOGEN 
3krd:B    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B  |   BINDING SITES, MYCOBACTERIUM TUBERCULOSIS, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME, FELLUTAMIDE B, INHIBITION, PROTEASE, THREONINE PROTEASE, VIRULENCE, AUTOCATALYTIC CLEAVAGE, ZYMOGEN 
3krd:D    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B  |   BINDING SITES, MYCOBACTERIUM TUBERCULOSIS, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME, FELLUTAMIDE B, INHIBITION, PROTEASE, THREONINE PROTEASE, VIRULENCE, AUTOCATALYTIC CLEAVAGE, ZYMOGEN 
3krd:F    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B  |   BINDING SITES, MYCOBACTERIUM TUBERCULOSIS, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME, FELLUTAMIDE B, INHIBITION, PROTEASE, THREONINE PROTEASE, VIRULENCE, AUTOCATALYTIC CLEAVAGE, ZYMOGEN 
3krd:I    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B  |   BINDING SITES, MYCOBACTERIUM TUBERCULOSIS, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME, FELLUTAMIDE B, INHIBITION, PROTEASE, THREONINE PROTEASE, VIRULENCE, AUTOCATALYTIC CLEAVAGE, ZYMOGEN 
3krd:K    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B  |   BINDING SITES, MYCOBACTERIUM TUBERCULOSIS, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME, FELLUTAMIDE B, INHIBITION, PROTEASE, THREONINE PROTEASE, VIRULENCE, AUTOCATALYTIC CLEAVAGE, ZYMOGEN 
3krd:O    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B  |   BINDING SITES, MYCOBACTERIUM TUBERCULOSIS, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME, FELLUTAMIDE B, INHIBITION, PROTEASE, THREONINE PROTEASE, VIRULENCE, AUTOCATALYTIC CLEAVAGE, ZYMOGEN 
3krd:S    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B  |   BINDING SITES, MYCOBACTERIUM TUBERCULOSIS, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME, FELLUTAMIDE B, INHIBITION, PROTEASE, THREONINE PROTEASE, VIRULENCE, AUTOCATALYTIC CLEAVAGE, ZYMOGEN 
3krd:U    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B  |   BINDING SITES, MYCOBACTERIUM TUBERCULOSIS, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME, FELLUTAMIDE B, INHIBITION, PROTEASE, THREONINE PROTEASE, VIRULENCE, AUTOCATALYTIC CLEAVAGE, ZYMOGEN 
3krd:W    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B  |   BINDING SITES, MYCOBACTERIUM TUBERCULOSIS, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME, FELLUTAMIDE B, INHIBITION, PROTEASE, THREONINE PROTEASE, VIRULENCE, AUTOCATALYTIC CLEAVAGE, ZYMOGEN 
3krd:Y    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B  |   BINDING SITES, MYCOBACTERIUM TUBERCULOSIS, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME, FELLUTAMIDE B, INHIBITION, PROTEASE, THREONINE PROTEASE, VIRULENCE, AUTOCATALYTIC CLEAVAGE, ZYMOGEN 
3krd:1    (LYS28) to   (THR226)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B  |   BINDING SITES, MYCOBACTERIUM TUBERCULOSIS, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, HYDROLASE, PROTEASOME, FELLUTAMIDE B, INHIBITION, PROTEASE, THREONINE PROTEASE, VIRULENCE, AUTOCATALYTIC CLEAVAGE, ZYMOGEN 
5dki:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:F    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:T    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dki:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:B    (THR33) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:F    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:K    (ILE12) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:P    (THR33) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:T    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5dkj:Y    (ILE12) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, TARGET DELIVERY, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
1z7q:A    (ASN39) to   (THR235)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1z7q:C    (GLY33) to   (ILE229)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1z7q:I     (THR1) to   (ASN194)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1z7q:L     (THR1) to   (ASP192)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1z7q:O    (ASN39) to   (THR235)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1z7q:Q    (GLY33) to   (ILE229)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1z7q:W     (THR1) to   (ASN194)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
1z7q:Z     (THR1) to   (ASP192)  CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION  |   20S, PROTEASOME, PA26, ACTIVATOR, MULTI-CATALYTIC PROTEASE, HYDROLASE-HYDROLASE ACTIVATOR COMPLEX 
4q1s:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4q1s:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4q1s:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4q1s:D    (SER27) to   (ASN225)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4q1s:F    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4q1s:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4q1s:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4q1s:O    (VAL32) to   (LYS237)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4q1s:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4q1s:Q    (THR29) to   (SER224)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4q1s:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4q1s:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4q1s:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4q1s:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN  |   PROTEASOME, NATURAL PRODUCT, QUINONE METHIDE, COVALENT BINDING, EXOSITE, HYDROLASE-TOXIN COMPLEX 
4qls:A    (VAL32) to   (THR239)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:B    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:C    (THR29) to   (LEU222)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:D    (SER27) to   (ASN225)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:G    (ASN32) to   (THR226)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:H     (THR1) to   (ASN194)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:K    (ILE12) to   (VAL193)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:O    (VAL32) to   (THR239)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:P    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:Q    (THR29) to   (LEU222)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:R    (SER27) to   (ASN225)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:U    (ASN32) to   (THR226)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:V     (THR1) to   (ASN194)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qls:Y    (ILE12) to   (VAL193)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:A    (VAL32) to   (THR239)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:B    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:D    (SER27) to   (ILE222)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:G    (ILE31) to   (ALA229)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:H    (VAL12) to   (ASN194)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:K     (THR1) to   (VAL193)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:O    (VAL32) to   (THR239)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:P    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:R    (SER27) to   (ILE222)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:U    (ILE31) to   (ALA229)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:V    (VAL12) to   (ASN194)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlq:Y    (ILE12) to   (VAL193)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:A    (VAL32) to   (THR239)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:B    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:C    (THR29) to   (SER224)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:D    (SER27) to   (ILE222)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:G    (ILE31) to   (THR226)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:H     (THR1) to   (ASN194)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:K    (ILE12) to   (VAL193)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:O    (VAL32) to   (THR239)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:P    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:Q    (THR29) to   (SER224)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:R    (SER27) to   (ILE222)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:U    (ILE31) to   (THR226)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:V     (THR1) to   (ASN194)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlt:Y    (ILE12) to   (VAL193)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:A    (VAL32) to   (THR239)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:B    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:C    (THR29) to   (LEU222)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:D    (SER27) to   (ASN225)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:G    (ASN32) to   (ALA229)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:H     (THR1) to   (ASN194)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:K     (THR1) to   (VAL193)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:O    (VAL32) to   (THR239)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:P    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:Q    (THR29) to   (LEU222)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:R    (SER27) to   (ASN225)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:U    (ASN32) to   (ALA229)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:V     (THR1) to   (ASN194)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qlu:Y     (THR1) to   (VAL193)  YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9  |   PROTEASOME, EPOXYKETONE, IMMUNOPROTEASOME INHIBITOR, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3mfe:B    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT  |   CATALYTIC DOMAIN, HYDROGEN BONDING, MYCOBACTERIUM TUBERCULOSIS, OXAZOLIDINONES, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN CARBONYLATION, PROTEIN CONFORMATION, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, THIAZOLES, HELIX MOVEMENT, HYDROLASE 
3mfe:F    (SER29) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT  |   CATALYTIC DOMAIN, HYDROGEN BONDING, MYCOBACTERIUM TUBERCULOSIS, OXAZOLIDINONES, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN CARBONYLATION, PROTEIN CONFORMATION, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, THIAZOLES, HELIX MOVEMENT, HYDROLASE 
3mfe:I    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT  |   CATALYTIC DOMAIN, HYDROGEN BONDING, MYCOBACTERIUM TUBERCULOSIS, OXAZOLIDINONES, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN CARBONYLATION, PROTEIN CONFORMATION, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, THIAZOLES, HELIX MOVEMENT, HYDROLASE 
3mfe:K    (LYS28) to   (THR226)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT  |   CATALYTIC DOMAIN, HYDROGEN BONDING, MYCOBACTERIUM TUBERCULOSIS, OXAZOLIDINONES, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN CARBONYLATION, PROTEIN CONFORMATION, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, THIAZOLES, HELIX MOVEMENT, HYDROLASE 
3mfe:M    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT  |   CATALYTIC DOMAIN, HYDROGEN BONDING, MYCOBACTERIUM TUBERCULOSIS, OXAZOLIDINONES, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN CARBONYLATION, PROTEIN CONFORMATION, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, THIAZOLES, HELIX MOVEMENT, HYDROLASE 
3mfe:O    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT  |   CATALYTIC DOMAIN, HYDROGEN BONDING, MYCOBACTERIUM TUBERCULOSIS, OXAZOLIDINONES, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN CARBONYLATION, PROTEIN CONFORMATION, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, THIAZOLES, HELIX MOVEMENT, HYDROLASE 
3mfe:Q    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT  |   CATALYTIC DOMAIN, HYDROGEN BONDING, MYCOBACTERIUM TUBERCULOSIS, OXAZOLIDINONES, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN CARBONYLATION, PROTEIN CONFORMATION, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, THIAZOLES, HELIX MOVEMENT, HYDROLASE 
3mfe:S    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT  |   CATALYTIC DOMAIN, HYDROGEN BONDING, MYCOBACTERIUM TUBERCULOSIS, OXAZOLIDINONES, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN CARBONYLATION, PROTEIN CONFORMATION, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, THIAZOLES, HELIX MOVEMENT, HYDROLASE 
3mfe:U    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT  |   CATALYTIC DOMAIN, HYDROGEN BONDING, MYCOBACTERIUM TUBERCULOSIS, OXAZOLIDINONES, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN CARBONYLATION, PROTEIN CONFORMATION, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, THIAZOLES, HELIX MOVEMENT, HYDROLASE 
3mfe:1    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT  |   CATALYTIC DOMAIN, HYDROGEN BONDING, MYCOBACTERIUM TUBERCULOSIS, OXAZOLIDINONES, PROTEASE INHIBITORS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN CARBONYLATION, PROTEIN CONFORMATION, PROTEIN SUBUNITS, SUBSTRATE SPECIFICITY, THIAZOLES, HELIX MOVEMENT, HYDROLASE 
3mg0:A    (VAL35) to   (THR225)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg0:B    (THR36) to   (PHE224)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg0:C    (THR35) to   (LEU224)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg0:D    (SER35) to   (ASN226)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg0:G    (ASN34) to   (SER225)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg0:H     (THR1) to   (ASN195)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg0:K     (THR1) to   (ASP191)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg0:O    (VAL35) to   (THR225)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg0:P    (GLY35) to   (PHE224)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg0:Q    (THR35) to   (LEU224)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg0:R    (SER35) to   (ASN226)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg0:T    (THR35) to   (GLY226)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg0:U    (ILE35) to   (SER225)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg0:V     (THR1) to   (ASN195)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg0:Y     (THR1) to   (ASP191)  STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB  |   20S PROTEASOME, HYDROLASE 
3mg4:A    (VAL35) to   (THR225)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:B    (GLY35) to   (ILE223)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:C    (THR35) to   (SER226)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:D    (THR36) to   (ASN226)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:F    (THR35) to   (GLY226)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:G    (ILE35) to   (ALA226)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:H     (THR1) to   (ASN195)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:K     (THR1) to   (VAL192)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:O    (VAL35) to   (THR225)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:P    (GLY35) to   (ILE223)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:Q    (THR35) to   (SER226)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:R    (THR36) to   (ASN226)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:T    (THR35) to   (VAL224)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:U    (ILE35) to   (THR223)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:V     (THR1) to   (ASN190)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg4:Y     (THR1) to   (ASP191)  STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1  |   20S PROTEASOME, HYDROLASE 
3mg6:A    (VAL35) to   (THR225)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:B    (THR36) to   (ILE223)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:C    (THR35) to   (LEU224)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:D    (SER35) to   (ASN226)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:H     (THR1) to   (ASN195)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:K    (ILE12) to   (ASP191)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:O    (VAL35) to   (THR225)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:P    (GLY35) to   (ILE223)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:Q    (THR35) to   (LEU224)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:R    (SER35) to   (ASN226)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:T    (THR35) to   (VAL224)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:V     (THR1) to   (ASN195)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg6:Y    (ILE12) to   (ASP191)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6  |   20S PROTEASOME, HYDROLASE 
3mg7:A    (VAL35) to   (THR225)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:B    (ALA37) to   (ILE223)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:C    (THR35) to   (LEU224)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:D    (SER35) to   (ASN226)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:F    (THR35) to   (VAL224)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:G    (ILE35) to   (ALA226)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:H     (THR1) to   (ASN195)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:K     (THR1) to   (VAL192)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:O    (VAL35) to   (THR225)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:P    (GLY35) to   (ILE223)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:Q    (THR35) to   (LEU224)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:R    (SER35) to   (ASN226)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:U    (ILE35) to   (ALA226)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:V     (THR1) to   (ASN195)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg7:Y    (ILE12) to   (ASP191)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8  |   20S PROTEASOME, HYDROLASE 
3mg8:A    (VAL35) to   (THR225)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mg8:B    (THR36) to   (ILE223)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mg8:C    (THR35) to   (LEU224)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mg8:D    (SER35) to   (ASN226)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mg8:F    (THR35) to   (VAL224)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mg8:G    (ILE35) to   (ALA226)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mg8:H     (THR1) to   (ASN195)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mg8:K     (THR1) to   (VAL192)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mg8:O    (VAL35) to   (THR225)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mg8:P    (GLY35) to   (ILE223)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mg8:R    (SER35) to   (ASN226)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mg8:T    (THR35) to   (VAL224)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mg8:V     (THR1) to   (ASN195)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mg8:Y    (ILE12) to   (ASP191)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16  |   20S PROTEASOME, HYDROLASE 
3mi0:A    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A  |   ENZYME INHIBITORS, LACTONES, PROTEASOME ENDOPEPTIDASE COMPLEX, MYCOBACTERIUM TUBERCULOSIS, HYDROLASE 
3mi0:B    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A  |   ENZYME INHIBITORS, LACTONES, PROTEASOME ENDOPEPTIDASE COMPLEX, MYCOBACTERIUM TUBERCULOSIS, HYDROLASE 
3mi0:D    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A  |   ENZYME INHIBITORS, LACTONES, PROTEASOME ENDOPEPTIDASE COMPLEX, MYCOBACTERIUM TUBERCULOSIS, HYDROLASE 
3mi0:F    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A  |   ENZYME INHIBITORS, LACTONES, PROTEASOME ENDOPEPTIDASE COMPLEX, MYCOBACTERIUM TUBERCULOSIS, HYDROLASE 
3mi0:I    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A  |   ENZYME INHIBITORS, LACTONES, PROTEASOME ENDOPEPTIDASE COMPLEX, MYCOBACTERIUM TUBERCULOSIS, HYDROLASE 
3mi0:K    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A  |   ENZYME INHIBITORS, LACTONES, PROTEASOME ENDOPEPTIDASE COMPLEX, MYCOBACTERIUM TUBERCULOSIS, HYDROLASE 
3mi0:M    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A  |   ENZYME INHIBITORS, LACTONES, PROTEASOME ENDOPEPTIDASE COMPLEX, MYCOBACTERIUM TUBERCULOSIS, HYDROLASE 
3mi0:O    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A  |   ENZYME INHIBITORS, LACTONES, PROTEASOME ENDOPEPTIDASE COMPLEX, MYCOBACTERIUM TUBERCULOSIS, HYDROLASE 
3mi0:Q    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A  |   ENZYME INHIBITORS, LACTONES, PROTEASOME ENDOPEPTIDASE COMPLEX, MYCOBACTERIUM TUBERCULOSIS, HYDROLASE 
3mi0:S    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A  |   ENZYME INHIBITORS, LACTONES, PROTEASOME ENDOPEPTIDASE COMPLEX, MYCOBACTERIUM TUBERCULOSIS, HYDROLASE 
3mi0:U    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A  |   ENZYME INHIBITORS, LACTONES, PROTEASOME ENDOPEPTIDASE COMPLEX, MYCOBACTERIUM TUBERCULOSIS, HYDROLASE 
3mi0:W    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A  |   ENZYME INHIBITORS, LACTONES, PROTEASOME ENDOPEPTIDASE COMPLEX, MYCOBACTERIUM TUBERCULOSIS, HYDROLASE 
3mi0:Y    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A  |   ENZYME INHIBITORS, LACTONES, PROTEASOME ENDOPEPTIDASE COMPLEX, MYCOBACTERIUM TUBERCULOSIS, HYDROLASE 
3mi0:1    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A  |   ENZYME INHIBITORS, LACTONES, PROTEASOME ENDOPEPTIDASE COMPLEX, MYCOBACTERIUM TUBERCULOSIS, HYDROLASE 
3mka:B    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT  |   MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, PROPEPTIDE, PROTEIN MATURATION, PROTEASOME ASSEMBLY, HYDROLASE 
3mka:F    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT  |   MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, PROPEPTIDE, PROTEIN MATURATION, PROTEASOME ASSEMBLY, HYDROLASE 
3mka:M    (LYS28) to   (THR226)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT  |   MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, PROPEPTIDE, PROTEIN MATURATION, PROTEASOME ASSEMBLY, HYDROLASE 
3mka:O    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT  |   MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, PROPEPTIDE, PROTEIN MATURATION, PROTEASOME ASSEMBLY, HYDROLASE 
3mka:S    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT  |   MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, PROPEPTIDE, PROTEIN MATURATION, PROTEASOME ASSEMBLY, HYDROLASE 
3mka:U    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT  |   MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, PROPEPTIDE, PROTEIN MATURATION, PROTEASOME ASSEMBLY, HYDROLASE 
3mka:W    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT  |   MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, PROPEPTIDE, PROTEIN MATURATION, PROTEASOME ASSEMBLY, HYDROLASE 
3mka:Y    (LYS28) to   (GLY227)  CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT  |   MYCOBACTERIUM TUBERCULOSIS, PROTEASOME ENDOPEPTIDASE COMPLEX, PROTEIN SUBUNITS, PROPEPTIDE, PROTEIN MATURATION, PROTEASOME ASSEMBLY, HYDROLASE 
4qux:A    (VAL32) to   (THR239)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:B    (GLY32) to   (ILE228)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:C    (THR29) to   (LEU222)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:D    (SER27) to   (ILE222)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:F    (THR31) to   (VAL227)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:G    (ILE31) to   (THR226)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:H     (THR1) to   (ASN194)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:K     (THR1) to   (ASP192)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:O    (VAL32) to   (THR239)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:P    (GLY32) to   (ILE228)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:Q    (THR29) to   (LEU222)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:R    (SER27) to   (ILE222)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:T    (THR31) to   (VAL227)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:U    (ILE31) to   (THR226)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:V     (THR1) to   (ASN194)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qux:Y     (THR1) to   (ASP192)  YCP BETA5-A49T-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv1:A    (VAL32) to   (THR239)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:B    (GLY32) to   (ILE228)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:C    (THR29) to   (LEU222)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:D    (SER27) to   (ILE222)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:G    (ILE31) to   (THR226)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:H     (THR1) to   (ASN194)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:K     (THR1) to   (ASP192)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:O    (VAL32) to   (THR239)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:P    (GLY32) to   (ILE228)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:Q    (THR29) to   (LEU222)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:R    (SER27) to   (ILE222)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:U    (ILE31) to   (THR226)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:V     (THR1) to   (ASN194)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qv1:Y     (THR1) to   (ASP192)  YCP BETA5-M45A MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4quy:A    (VAL32) to   (THR239)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:B    (GLY32) to   (ILE228)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:C    (THR29) to   (LEU222)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:D    (SER27) to   (ILE222)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:G    (ILE31) to   (THR226)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:H     (THR1) to   (ASN194)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:K     (THR1) to   (ASP192)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:O    (VAL32) to   (THR239)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:P    (GLY32) to   (ILE228)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:Q    (THR29) to   (LEU222)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:R    (SER27) to   (ILE222)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:U    (ILE31) to   (THR226)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:V     (THR1) to   (ASN194)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4quy:Y     (THR1) to   (ASP192)  YCP BETA5-A49S-MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:A    (VAL32) to   (THR239)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:B    (GLY32) to   (ILE228)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:C    (THR29) to   (LEU222)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:D    (SER27) to   (ILE222)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:G    (ILE31) to   (THR226)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:H     (THR1) to   (ASN194)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:K     (THR1) to   (ASP192)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:O    (VAL32) to   (THR239)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:P    (GLY32) to   (ILE228)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:Q    (THR29) to   (LEU222)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:R    (SER27) to   (ILE222)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:U    (ILE31) to   (THR226)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:V     (THR1) to   (ASN194)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv0:Y     (THR1) to   (ASP192)  YCP BETA5-A49T-A50V-DOUBLE MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:A    (VAL32) to   (THR239)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:B    (GLY32) to   (ILE228)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:C    (THR29) to   (LEU222)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:D    (SER27) to   (ILE222)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:G    (ILE31) to   (THR226)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:H     (THR1) to   (ASN194)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:K     (THR1) to   (ASP192)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:O    (VAL32) to   (THR239)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:P    (GLY32) to   (ILE228)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:Q    (THR29) to   (LEU222)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:R    (SER27) to   (ILE222)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:U    (ILE31) to   (THR226)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:V     (THR1) to   (ASN194)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv3:Y     (THR1) to   (ASP192)  YCP BETA5-M45V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:A    (VAL32) to   (THR239)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:B    (GLY32) to   (ILE228)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:C    (THR29) to   (LEU222)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:D    (SER27) to   (ILE222)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:F    (THR31) to   (VAL227)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:G    (ILE31) to   (THR226)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:H     (THR1) to   (ASN194)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:K     (THR1) to   (ASP192)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:O    (VAL32) to   (THR239)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:P    (GLY32) to   (ILE228)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:Q    (THR29) to   (LEU222)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:R    (SER27) to   (ILE222)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:T    (THR31) to   (VAL227)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:U    (ILE31) to   (THR226)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:V     (THR1) to   (ASN194)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv4:Y     (THR1) to   (ASP192)  YCP BETA5-M45T MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:A    (VAL32) to   (THR239)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:B    (GLY32) to   (ILE228)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:C    (THR29) to   (LEU222)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:D    (SER27) to   (ILE222)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:G    (ILE31) to   (THR226)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:H     (THR1) to   (ASN194)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:K     (THR1) to   (ASP192)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:O    (VAL32) to   (THR239)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:P    (GLY32) to   (ILE228)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:Q    (THR29) to   (LEU222)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:R    (SER27) to   (ILE222)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:U    (ILE31) to   (THR226)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:V     (THR1) to   (ASN194)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv5:Y     (THR1) to   (ASP192)  YCP BETA5-M45I MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:A    (VAL32) to   (THR239)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:B    (GLY32) to   (ILE228)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:C    (THR29) to   (LEU222)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:D    (SER27) to   (ILE222)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:G    (ILE31) to   (THR226)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:H     (THR1) to   (ASN194)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:K     (THR1) to   (ASP192)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:O    (VAL32) to   (THR239)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:P    (GLY32) to   (ILE228)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:Q    (THR29) to   (LEU222)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:R    (SER27) to   (ILE222)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:U    (ILE31) to   (THR226)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:V     (THR1) to   (ASN194)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv6:Y     (THR1) to   (ASP192)  YCP BETA5-A49V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:A    (VAL32) to   (THR239)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:B    (GLY32) to   (ILE228)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:C    (THR29) to   (LEU222)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:D    (SER27) to   (ILE222)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:G    (ILE31) to   (THR226)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:H     (THR1) to   (ASN194)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:K     (THR1) to   (ASP192)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:O    (VAL32) to   (THR239)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:P    (GLY32) to   (ILE228)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:Q    (THR29) to   (LEU222)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:R    (SER27) to   (ILE222)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:U    (ILE31) to   (THR226)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:V     (THR1) to   (ASN194)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv7:Y     (THR1) to   (ASP192)  YCP BETA5-A50V MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:A    (VAL32) to   (THR239)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:B    (GLY32) to   (ILE228)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:C    (THR29) to   (LEU222)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:D    (SER27) to   (ILE222)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:G    (ILE31) to   (THR226)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:H     (THR1) to   (ASN194)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:K     (THR1) to   (ASP192)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:O    (VAL32) to   (THR239)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:P    (GLY32) to   (ILE228)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:Q    (THR29) to   (LEU222)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:R    (SER27) to   (ILE222)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:U    (ILE31) to   (THR226)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:V     (THR1) to   (ASN194)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv8:Y     (THR1) to   (ASP192)  YCP BETA5-C52F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:A    (VAL32) to   (THR239)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:B    (GLY32) to   (ILE228)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:C    (THR29) to   (LEU222)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:D    (SER27) to   (ILE222)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:G    (ILE31) to   (THR226)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:H     (THR1) to   (ASN194)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:K     (THR1) to   (ASP192)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:O    (VAL32) to   (THR239)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:P    (GLY32) to   (ILE228)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:Q    (THR29) to   (LEU222)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:R    (SER27) to   (ILE222)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:U    (ILE31) to   (THR226)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:V     (THR1) to   (ASN194)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qv9:Y     (THR1) to   (ASP192)  YCP BETA5-C63F MUTANT  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE 
4qvl:A    (VAL32) to   (THR239)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:B    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:C    (THR29) to   (LEU222)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:D    (SER27) to   (ILE222)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:F    (THR31) to   (VAL227)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:G    (ILE31) to   (THR226)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:H    (VAL12) to   (ASN194)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:K     (THR1) to   (ASP192)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:O    (VAL32) to   (THR239)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:P    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:Q    (THR29) to   (LEU222)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:R    (SER27) to   (ILE222)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:T    (THR31) to   (VAL227)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:U    (ILE31) to   (THR226)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:V    (VAL12) to   (ASN194)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvl:Y     (THR1) to   (ASP192)  YCP IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:A    (VAL32) to   (THR239)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:B    (GLY32) to   (ILE228)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:C    (THR29) to   (LEU222)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:D    (SER27) to   (ILE222)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:G    (ILE31) to   (THR226)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:H    (VAL12) to   (ASN194)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:K     (THR1) to   (ASP192)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:O    (VAL32) to   (THR239)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:P    (GLY32) to   (ILE228)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:Q    (THR29) to   (LEU222)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:R    (SER27) to   (ILE222)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:U    (ILE31) to   (THR226)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:V    (VAL12) to   (ASN194)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvm:Y     (THR1) to   (ASP192)  YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:A    (VAL32) to   (THR239)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:B    (THR33) to   (ILE228)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:C    (THR29) to   (LEU222)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:D    (SER27) to   (ILE222)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:G    (ILE31) to   (THR226)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:H    (VAL12) to   (ASN194)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:K     (THR1) to   (ASP192)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:O    (VAL32) to   (THR239)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:P    (GLY32) to   (ILE228)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:Q    (THR29) to   (LEU222)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:R    (SER27) to   (ILE222)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:U    (ILE31) to   (THR226)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:V    (VAL12) to   (ASN194)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvn:Y     (THR1) to   (ASP192)  YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:A    (VAL32) to   (THR239)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:B    (THR33) to   (ILE228)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:C    (THR29) to   (LEU222)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:D    (SER27) to   (ILE222)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:F    (THR31) to   (GLY229)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:G    (ILE31) to   (THR226)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:H    (VAL12) to   (ASN194)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:K     (THR1) to   (ASP192)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:O    (VAL32) to   (THR239)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:P    (THR33) to   (ILE228)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:Q    (THR29) to   (LEU222)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:R    (SER27) to   (ILE222)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:T    (THR31) to   (GLY229)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:U    (ILE31) to   (THR226)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:V    (VAL12) to   (ASN194)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvp:Y     (THR1) to   (ASP192)  YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvq:A    (VAL32) to   (THR239)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:B    (GLY32) to   (ILE228)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:C    (THR29) to   (LEU222)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:D    (SER27) to   (ILE222)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:F    (THR31) to   (GLY229)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:G    (ILE31) to   (THR226)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:H    (VAL12) to   (ASN194)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:K    (ILE12) to   (ASP192)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:O    (VAL32) to   (THR239)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:P    (GLY32) to   (ILE228)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:Q    (THR29) to   (LEU222)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:R    (SER27) to   (ILE222)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:T    (THR31) to   (GLY229)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:U    (ILE31) to   (THR226)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:V    (VAL12) to   (ASN194)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvq:Y    (ILE12) to   (ASP192)  YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvv:A    (VAL32) to   (THR239)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:B    (GLY32) to   (ILE228)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:C    (THR29) to   (LEU222)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:D    (SER27) to   (ILE222)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:F    (THR31) to   (VAL227)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:G    (ILE31) to   (THR226)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:H     (THR1) to   (ASN194)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:K     (THR1) to   (ASP192)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:L    (PHE20) to   (PHE216)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:O    (VAL32) to   (THR239)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:P    (GLY32) to   (ILE228)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:Q    (THR29) to   (LEU222)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:R    (SER27) to   (ILE222)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:T    (THR31) to   (VAL227)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:U    (ILE31) to   (THR226)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:V     (THR1) to   (ASN194)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:Y     (THR1) to   (ASP192)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvv:Z    (PHE20) to   (PHE216)  YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvw:A    (VAL32) to   (THR239)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:B    (GLY32) to   (ILE228)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:C    (THR29) to   (LEU222)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:D    (SER27) to   (ILE222)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:G    (ILE31) to   (THR226)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:H    (VAL12) to   (ASN194)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:K     (THR1) to   (ASP192)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:O    (VAL32) to   (THR239)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:P    (GLY32) to   (ILE228)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:Q    (THR29) to   (LEU222)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:R    (SER27) to   (ILE222)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:U    (ILE31) to   (THR226)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:V    (VAL12) to   (ASN194)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvw:Y     (THR1) to   (ASP192)  YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4qvy:A    (VAL32) to   (THR239)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:B    (GLY32) to   (ILE228)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:C    (THR29) to   (LEU222)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:D    (SER27) to   (ILE222)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:F    (THR31) to   (VAL227)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:G    (ILE31) to   (THR226)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:H     (THR1) to   (ASN194)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:K     (THR1) to   (ASP192)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:O    (VAL32) to   (THR239)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:P    (GLY32) to   (ILE228)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:Q    (THR29) to   (LEU222)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:R    (SER27) to   (ILE222)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:T    (THR31) to   (VAL227)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:U    (ILE31) to   (THR226)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:V     (THR1) to   (ASN194)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qvy:Y     (THR1) to   (ASP192)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:A    (VAL32) to   (THR239)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:B    (GLY32) to   (ILE228)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:C    (THR29) to   (LEU222)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:D    (SER27) to   (ILE222)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:F    (THR31) to   (VAL227)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:G    (ILE31) to   (THR226)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:H     (THR1) to   (ASN194)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:K     (THR1) to   (ASP192)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:O    (VAL32) to   (THR239)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:P    (GLY32) to   (ILE228)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:Q    (THR29) to   (LEU222)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:R    (SER27) to   (ILE222)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:T    (THR31) to   (VAL227)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:U    (ILE31) to   (THR226)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:V     (THR1) to   (ASN194)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw0:Y     (THR1) to   (ASP192)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:A    (VAL32) to   (THR239)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:B    (THR33) to   (ILE228)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:C    (THR29) to   (LEU222)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:D    (SER27) to   (ILE222)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:G    (ILE31) to   (THR226)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:H    (VAL12) to   (ASN194)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:K     (THR1) to   (ASP192)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:O    (VAL32) to   (THR239)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:P    (THR33) to   (ILE228)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:Q    (THR29) to   (LEU222)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:R    (SER27) to   (ILE222)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:U    (ILE31) to   (THR226)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:V    (VAL12) to   (ASN194)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw1:Y     (THR1) to   (ASP192)  YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:A    (VAL32) to   (THR239)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:B    (GLY32) to   (ILE228)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:C    (THR29) to   (LEU222)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:D    (SER27) to   (ILE222)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:G    (ILE31) to   (ALA229)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:H    (VAL12) to   (ASN194)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:K     (THR1) to   (ASP192)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:O    (VAL32) to   (THR239)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:P    (GLY32) to   (ILE228)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:Q    (THR29) to   (LEU222)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:R    (SER27) to   (ILE222)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:U    (ILE31) to   (ALA229)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:V    (VAL12) to   (ASN194)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw5:Y     (THR1) to   (ASP192)  YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:A    (VAL32) to   (THR239)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:B    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:C    (THR29) to   (LEU222)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:D    (SER27) to   (ILE222)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:G    (ILE31) to   (ALA229)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:H    (VAL12) to   (ASN194)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:K    (ILE12) to   (ASP192)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:O    (VAL32) to   (THR239)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:P    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:Q    (THR29) to   (LEU222)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:R    (SER27) to   (ILE222)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:U    (ILE31) to   (ALA229)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:V    (VAL12) to   (ASN194)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw4:Y     (THR1) to   (ASP192)  YCP IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:A    (VAL32) to   (THR239)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:B    (GLY32) to   (ILE228)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:C    (THR29) to   (LEU222)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:D    (SER27) to   (ILE222)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:G    (ILE31) to   (ALA229)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:H    (VAL12) to   (ASN194)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:K     (THR1) to   (ASP192)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:O    (VAL32) to   (THR239)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:P    (GLY32) to   (ILE228)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:Q    (THR29) to   (LEU222)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:R    (SER27) to   (ILE222)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:U    (ILE31) to   (ALA229)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:V    (VAL12) to   (ASN194)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qw6:Y     (THR1) to   (ASP192)  YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:A    (VAL32) to   (THR239)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:B    (GLY32) to   (ILE228)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:C    (THR29) to   (LEU222)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:D    (SER27) to   (ILE222)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:G    (ILE31) to   (ALA229)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:H    (VAL12) to   (ASN194)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:K     (THR1) to   (VAL193)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:O    (VAL32) to   (THR239)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:P    (GLY32) to   (ILE228)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:Q    (THR29) to   (LEU222)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:R    (SER27) to   (ILE222)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:U    (ILE31) to   (ALA229)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:V    (VAL12) to   (ASN194)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwj:Y     (THR1) to   (VAL193)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:A    (VAL32) to   (THR239)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:B    (GLY32) to   (ILE228)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:C    (THR29) to   (LEU222)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:D    (SER27) to   (ILE222)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:G    (ILE31) to   (ALA229)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:H    (VAL12) to   (ASN194)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:K     (THR1) to   (ASP192)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:O    (VAL32) to   (THR239)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:P    (GLY32) to   (ILE228)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:Q    (THR29) to   (LEU222)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:R    (SER27) to   (ILE222)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:U    (ILE31) to   (ALA229)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:V    (VAL12) to   (ASN194)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwf:Y     (THR1) to   (ASP192)  YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:A    (VAL32) to   (THR239)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:B    (GLY32) to   (ILE228)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:C    (THR29) to   (LEU222)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:D    (SER27) to   (ILE222)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:F    (THR31) to   (GLY229)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:G    (ILE31) to   (ALA229)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:H    (VAL12) to   (ASN194)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:K     (THR1) to   (VAL193)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:L    (PHE20) to   (PHE216)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:O    (VAL32) to   (THR239)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:P    (GLY32) to   (ILE228)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:Q    (THR29) to   (LEU222)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:R    (SER27) to   (ILE222)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:T    (THR31) to   (GLY229)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:U    (ILE31) to   (ALA229)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:V    (VAL12) to   (ASN194)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:Y     (THR1) to   (VAL193)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwg:Z    (PHE20) to   (PHE216)  YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:A    (VAL32) to   (THR239)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:B    (GLY32) to   (ILE228)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:C    (THR29) to   (LEU222)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:D    (SER27) to   (ILE222)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:G    (ILE31) to   (ALA229)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:H    (VAL12) to   (ASN194)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:K     (THR1) to   (VAL193)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:O    (VAL32) to   (THR239)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:P    (GLY32) to   (ILE228)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:Q    (THR29) to   (LEU222)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:R    (SER27) to   (ILE222)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:U    (ILE31) to   (ALA229)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:V    (VAL12) to   (ASN194)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwk:Y     (THR1) to   (VAL193)  YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:A    (VAL32) to   (THR239)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:B    (GLY32) to   (ILE228)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:C    (THR29) to   (LEU222)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:D    (SER27) to   (ILE222)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:G    (ILE31) to   (ALA229)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:H    (VAL12) to   (ASN194)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:K     (THR1) to   (VAL193)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:O    (VAL32) to   (THR239)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:P    (GLY32) to   (ILE228)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:Q    (THR29) to   (LEU222)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:R    (SER27) to   (ILE222)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:U    (ILE31) to   (ALA229)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:V    (VAL12) to   (ASN194)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwl:Y     (THR1) to   (VAL193)  YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:A    (VAL32) to   (THR239)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:B    (GLY32) to   (ILE228)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:C    (THR29) to   (LEU222)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:D    (SER27) to   (ILE222)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:G    (ILE31) to   (ALA229)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:H    (VAL12) to   (ASN194)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:K     (THR1) to   (VAL193)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:O    (VAL32) to   (THR239)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:P    (GLY32) to   (ILE228)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:Q    (THR29) to   (LEU222)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:R    (SER27) to   (ILE222)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:U    (ILE31) to   (ALA229)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:V    (VAL12) to   (ASN194)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:Y     (THR1) to   (ASP192)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwr:b     (THR1) to   (TYR189)  YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:A    (VAL32) to   (THR239)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:B    (GLY32) to   (ILE228)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:C    (THR29) to   (LEU222)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:D    (SER27) to   (ILE222)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:G    (ILE31) to   (ALA229)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:H    (VAL12) to   (ASN194)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:K     (THR1) to   (ASP192)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:O    (VAL32) to   (THR239)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:P    (GLY32) to   (ILE228)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:Q    (THR29) to   (LEU222)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:R    (SER27) to   (ILE222)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:U    (ILE31) to   (ALA229)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:V    (VAL12) to   (ASN194)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qws:Y     (THR1) to   (ASP192)  YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:A    (VAL32) to   (THR239)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:B    (THR33) to   (ILE228)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:C    (THR29) to   (LEU222)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:D    (SER27) to   (ILE222)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:G    (ILE31) to   (THR226)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:H     (THR1) to   (ASN194)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:K     (THR1) to   (ASP192)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:O    (VAL32) to   (THR239)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:P    (THR33) to   (ILE228)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:Q    (THR29) to   (LEU222)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:R    (SER27) to   (ILE222)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:U    (ILE31) to   (THR226)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:V    (VAL12) to   (ASN194)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:Y     (THR1) to   (ASP192)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwu:Z    (PHE20) to   (GLU218)  YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:A    (VAL32) to   (THR239)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:B    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:C    (THR29) to   (LEU222)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:D    (SER27) to   (ILE222)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:G    (ILE31) to   (ALA229)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:H    (VAL12) to   (ASN194)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:K     (THR1) to   (ASP192)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:O    (VAL32) to   (THR239)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:P    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:Q    (THR29) to   (LEU222)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:R    (SER27) to   (ILE222)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:U    (ILE31) to   (ALA229)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:V    (VAL12) to   (ASN194)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qwx:Y     (THR1) to   (ASP192)  YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:A    (VAL32) to   (THR239)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:B    (GLY32) to   (ILE228)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:C    (THR29) to   (LEU222)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:D    (SER27) to   (ILE222)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:G    (ILE31) to   (THR226)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:H    (VAL12) to   (ASN194)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:K     (THR1) to   (VAL193)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:O    (VAL32) to   (THR239)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:P    (GLY32) to   (ILE228)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:Q    (THR29) to   (LEU222)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:R    (SER27) to   (ILE222)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:U    (ILE31) to   (THR226)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:V    (VAL12) to   (ASN194)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qxj:Y     (THR1) to   (ASP192)  YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:A    (VAL32) to   (THR239)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:B    (GLY32) to   (ILE228)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:C    (THR29) to   (LEU222)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:D    (SER27) to   (ILE222)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:G    (ILE31) to   (THR226)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:H    (VAL12) to   (ASN194)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:K    (ILE12) to   (ASP192)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:O    (VAL32) to   (THR239)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:P    (GLY32) to   (ILE228)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:Q    (THR29) to   (LEU222)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:R    (SER27) to   (ILE222)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:U    (ILE31) to   (THR226)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:V    (VAL12) to   (ASN194)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz0:Y    (ILE12) to   (ASP192)  YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:A    (VAL32) to   (THR239)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:B    (GLY32) to   (ILE228)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:C    (THR29) to   (LEU222)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:D    (SER27) to   (ILE222)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:G    (ILE31) to   (ALA229)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:H    (VAL12) to   (ASN194)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:K    (ILE12) to   (VAL193)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:O    (VAL32) to   (THR239)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:P    (GLY32) to   (ILE228)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:Q    (THR29) to   (LEU222)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:R    (SER27) to   (ILE222)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:U    (ILE31) to   (ALA229)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:V    (VAL12) to   (ASN194)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz2:Y    (ILE12) to   (VAL193)  YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:A    (VAL32) to   (THR239)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:B    (GLY32) to   (ILE228)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:C    (THR29) to   (LEU222)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:D    (SER27) to   (ILE222)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:G    (ILE31) to   (THR226)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:H     (THR1) to   (ASN194)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:K     (THR1) to   (VAL193)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:O    (VAL32) to   (THR239)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:P    (GLY32) to   (ILE228)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:Q    (THR29) to   (LEU222)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:R    (SER27) to   (ILE222)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:U    (ILE31) to   (THR226)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:V     (THR1) to   (ASN194)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz3:Y     (THR1) to   (VAL193)  YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:A    (VAL32) to   (THR239)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:B    (GLY32) to   (ILE228)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:C    (THR29) to   (LEU222)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:D    (SER27) to   (ILE222)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:G    (ILE31) to   (THR226)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:H    (VAL12) to   (ASN194)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:K     (THR1) to   (ASP192)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:N     (THR1) to   (TYR189)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:O    (VAL32) to   (THR239)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:P    (GLY32) to   (ILE228)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:Q    (THR29) to   (LEU222)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:R    (SER27) to   (ILE222)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:U    (ILE31) to   (THR226)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:V    (VAL12) to   (ASN194)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:Y     (THR1) to   (ASP192)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz4:b     (THR1) to   (TYR189)  YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:A    (VAL32) to   (THR239)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:B    (GLY32) to   (ILE228)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:C    (THR29) to   (LEU222)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:D    (SER27) to   (ILE222)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:G    (ILE31) to   (THR226)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:H    (VAL12) to   (ASN194)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:K     (THR1) to   (VAL193)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:O    (VAL32) to   (THR239)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:P    (GLY32) to   (ILE228)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:Q    (THR29) to   (LEU222)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:R    (SER27) to   (ILE222)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:U    (ILE31) to   (THR226)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:V    (VAL12) to   (ASN194)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz5:Y     (THR1) to   (VAL193)  YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:A    (VAL32) to   (THR239)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:B    (GLY32) to   (ILE228)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:C    (THR29) to   (LEU222)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:D    (SER27) to   (ILE222)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:F    (THR31) to   (GLY229)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:G    (ILE31) to   (THR226)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:H    (VAL12) to   (ASN194)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:K     (THR1) to   (VAL193)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:O    (VAL32) to   (THR239)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:P    (GLY32) to   (ILE228)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:Q    (THR29) to   (LEU222)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:R    (SER27) to   (ILE222)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:U    (ILE31) to   (THR226)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:V    (VAL12) to   (ASN194)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qz6:Y     (THR1) to   (VAL193)  YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:A    (VAL32) to   (THR239)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:B    (GLY32) to   (ILE228)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:C    (THR29) to   (LEU222)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:D    (SER27) to   (ILE222)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:G    (ILE31) to   (THR226)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:H    (VAL12) to   (ASN194)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:K     (THR1) to   (ASP192)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:N     (THR1) to   (TYR189)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:O    (VAL32) to   (THR239)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:P    (GLY32) to   (ILE228)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:Q    (THR29) to   (LEU222)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:R    (SER27) to   (ILE222)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:U    (ILE31) to   (THR226)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:V    (VAL12) to   (ASN194)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:Y     (THR1) to   (ASP192)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzw:b     (THR1) to   (TYR189)  YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:A    (VAL32) to   (THR239)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:B    (THR33) to   (ILE228)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:C    (THR29) to   (LEU222)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:D    (SER27) to   (ILE222)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:G    (ILE31) to   (THR226)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:H     (THR1) to   (ASN194)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:K     (THR1) to   (VAL193)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:N     (THR1) to   (TYR189)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:O    (VAL32) to   (THR239)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:P    (THR33) to   (ILE228)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:Q    (THR29) to   (LEU222)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:R    (SER27) to   (ILE222)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:U    (ILE31) to   (THR226)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:V    (VAL12) to   (ASN194)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:Y     (THR1) to   (VAL193)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzx:b     (THR1) to   (TYR189)  YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:A    (VAL32) to   (THR239)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:B    (GLY32) to   (ILE228)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:C    (THR29) to   (LEU222)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:D    (SER27) to   (ILE222)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:G    (ILE31) to   (THR226)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:H     (THR1) to   (ASN194)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:K     (THR1) to   (ASP192)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:O    (VAL32) to   (THR239)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:P    (GLY32) to   (ILE228)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:Q    (THR29) to   (LEU222)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:R    (SER27) to   (ILE222)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:U    (ILE31) to   (THR226)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:V     (THR1) to   (ASN194)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r00:Y     (THR1) to   (ASP192)  YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:A    (VAL32) to   (THR239)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:B    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:C    (THR29) to   (LEU222)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:D    (SER27) to   (ILE222)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:G    (ILE31) to   (THR226)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:H     (THR1) to   (ASN194)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:K     (THR1) to   (ASP192)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:O    (VAL32) to   (THR239)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:P    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:Q    (THR29) to   (LEU222)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:R    (SER27) to   (ILE222)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:U    (ILE31) to   (THR226)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:V     (THR1) to   (ASN194)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4qzz:Y     (THR1) to   (ASP192)  YCP IN COMPLEX WITH OMURALIDE  |   CANCER, PROTEASOME, BORTEZOMIB, DRUG RESISTANCE, BINDING ANALYSIS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:A    (VAL32) to   (THR239)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:B    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:D    (SER27) to   (ILE222)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:F    (THR31) to   (GLY229)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:G    (ILE31) to   (THR226)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:H     (THR1) to   (ASN194)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:K     (THR1) to   (ASP192)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:O    (VAL32) to   (THR239)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:P    (GLY32) to   (ILE228)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:Q    (THR29) to   (LEU222)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:R    (SER27) to   (ILE222)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:T    (THR31) to   (GLY229)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:U    (ILE31) to   (SER228)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:V     (THR1) to   (ASN194)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r02:Y     (THR1) to   (ASP192)  YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)  |   CANCER, PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, REVERSIBLE COVALENT LIGAND, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:A    (VAL32) to   (THR239)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:B    (GLY32) to   (ILE228)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:C    (THR29) to   (LEU222)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:D    (SER27) to   (ILE222)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:F    (THR31) to   (VAL227)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:G    (ILE31) to   (SER228)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:H     (THR1) to   (ASN194)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:K     (THR2) to   (ASP192)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:O    (VAL32) to   (THR239)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:P    (GLY32) to   (ILE228)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:Q    (THR29) to   (LEU222)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:R    (SER27) to   (ILE222)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:T    (THR31) to   (VAL227)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:U    (ILE31) to   (SER228)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:V     (THR1) to   (ASN194)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r17:Y     (THR2) to   (ASP192)  LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:A    (VAL32) to   (THR239)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:B    (GLY32) to   (ILE228)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:C    (THR29) to   (LEU222)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:D    (SER27) to   (ILE222)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:F    (THR31) to   (GLY229)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:G    (ILE31) to   (THR226)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:H     (THR1) to   (ASN194)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:K     (THR2) to   (ASP192)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:O    (VAL32) to   (THR239)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:P    (GLY32) to   (ILE228)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:Q    (THR29) to   (LEU222)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:R    (SER27) to   (ILE222)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:T    (THR31) to   (GLY229)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:U    (ILE31) to   (THR226)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:V     (THR1) to   (ASN194)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r18:Y     (THR2) to   (ASP192)  LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME  |   PROTEASOME, DRUG DEVELOPMENT, BINDING ANALYSIS, UMPOLUNG, CROSSLINK, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4r3o:C    (THR33) to   (VAL227)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:D    (THR31) to   (PRO222)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:E    (ALA37) to   (PHE229)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:H    (VAL12) to   (GLY191)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:I    (ILE12) to   (PRO188)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:L    (VAL12) to   (ASN191)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:N     (THR9) to   (GLY201)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:Q    (THR33) to   (VAL227)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:S    (ALA37) to   (PHE229)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:V    (VAL12) to   (GLY191)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:W    (ILE12) to   (ARG187)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:Z    (VAL12) to   (ASN191)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
4r3o:2     (THR9) to   (GLY201)  HUMAN CONSTITUTIVE 20S PROTEASOME  |   HYDROLASE 
5fgd:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:G    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:K    (ALA-2) to   (ASP192)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:U    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgd:Y     (ALA1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fg7:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg7:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-T1A MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:F    (THR31) to   (VAL227)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:G    (ILE31) to   (SER228)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:U    (ILE31) to   (SER228)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fg9:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5fge:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:F    (THR31) to   (GLY229)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:G    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:K     (ALA1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:T    (THR31) to   (GLY229)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:U    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fge:Y     (ALA1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:G    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:K     (ALA1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:U    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fgf:Y     (ALA1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:G    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:U    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5fhs:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
3nzj:A    (VAL35) to   (THR225)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:B    (THR36) to   (ILE223)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:C    (THR35) to   (LEU224)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:D    (SER35) to   (ASP225)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:F    (THR35) to   (VAL224)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:H     (THR1) to   (ASN195)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:K     (THR1) to   (ASP191)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:O    (VAL35) to   (THR225)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:P    (THR36) to   (ILE223)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:Q    (THR35) to   (LEU224)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:R    (SER35) to   (ASP225)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:T    (THR35) to   (VAL224)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:V     (THR1) to   (ASN195)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzj:Y    (ILE12) to   (ASP191)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:A    (VAL35) to   (THR225)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:B    (THR36) to   (ILE223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:C    (THR35) to   (LEU224)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:D    (SER35) to   (ASP225)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:F    (THR35) to   (GLY226)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:G    (ASN34) to   (THR223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:H     (THR1) to   (ASN195)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:K     (THR1) to   (VAL192)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:O    (VAL35) to   (THR225)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:P    (THR36) to   (ILE223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:Q    (THR35) to   (LEU224)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:R    (SER35) to   (ASP225)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:U    (ASN34) to   (THR223)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:V     (THR1) to   (ASN195)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3nzw:Y     (THR1) to   (VAL192)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B  |   UBIQUITIN, PROTEIN DEGRADATION, N-TERMINAL NUCLEOPHILIC HYDROLASE, 19S REGULATORY PARTICLE, UBIQUITIN-TAGGED SUBSTRATES, CYTOSOL, NUCLEUS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3d29:A    (VAL35) to   (THR225)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:B    (GLY35) to   (ILE223)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:C    (THR35) to   (LEU224)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:D    (THR36) to   (ASP225)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:G    (ASN34) to   (THR223)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:H     (THR1) to   (ASN195)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:K    (ILE12) to   (VAL192)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:O    (VAL35) to   (THR225)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:P    (GLY35) to   (ILE223)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:Q    (THR35) to   (LEU224)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:R    (THR36) to   (ASP225)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:U    (ASN34) to   (THR223)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:V     (THR1) to   (ASN195)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3d29:Y    (ILE12) to   (VAL192)  PROTEASOME INHIBITION BY FELLUTAMIDE B  |   ANTI-PARALLEL BETA-SHEET STRUCTURE FLANKED BY ALPHA-HELICES, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, PROTEASOME, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
4cr3:2    (VAL12) to   (ARG188)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
4cr3:5     (THR1) to   (ASP192)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
4cr4:5     (THR1) to   (VAL193)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
4cr4:6     (GLY1) to   (GLU209)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
4cr4:A    (ASN39) to   (ALA238)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
4cr4:C    (GLY33) to   (PRO232)  DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME  |   HYDROLASE, AAA-ATPASE, ATP-ANALOG, CLASSIFICATION 
3oeu:A    (VAL35) to   (THR225)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:B    (ALA37) to   (ILE223)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:C    (THR35) to   (LEU224)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:D    (SER35) to   (ASN226)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:F    (THR35) to   (VAL224)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:G    (ASN34) to   (ALA226)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:H     (THR1) to   (ASN195)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:K     (THR1) to   (VAL192)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:O    (VAL35) to   (THR225)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:P    (GLY35) to   (ILE223)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:Q    (THR35) to   (LEU224)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:R    (SER35) to   (ASN226)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:T    (THR35) to   (VAL224)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:V     (THR1) to   (ASN195)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oeu:Y    (ILE12) to   (ASP191)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:A    (VAL35) to   (THR225)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:B    (THR36) to   (ILE223)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:C    (THR35) to   (LEU224)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:D    (THR36) to   (ASN226)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:F    (THR35) to   (GLY226)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:G    (ASN34) to   (ALA226)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:H     (THR1) to   (ASN195)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:K     (THR1) to   (VAL192)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:O    (VAL35) to   (THR225)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:P    (GLY35) to   (ILE223)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:Q    (THR35) to   (LEU224)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:R    (SER35) to   (ASP225)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:U    (ASN34) to   (ALA226)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:V     (THR1) to   (ASN195)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3oev:Y     (THR1) to   (ASP191)  STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25  |   20S PROTEASOME, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
3dy3:A    (VAL35) to   (THR225)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:B    (THR36) to   (ILE223)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:C    (THR35) to   (LEU224)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:D    (SER35) to   (ASN226)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:F    (THR35) to   (VAL224)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:G    (ASN34) to   (THR223)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:H     (THR1) to   (ASN195)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:K     (THR1) to   (ASP191)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:O    (VAL35) to   (THR225)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:P    (THR36) to   (ILE223)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:Q    (THR35) to   (LEU224)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:R    (SER35) to   (ASN226)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:T    (THR35) to   (VAL224)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:U    (ASN34) to   (THR223)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:V     (THR1) to   (ASN195)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3dy3:Y     (THR1) to   (ASP191)  CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN  |   PROTEASOME, INHIBITOR, PROTEIN DEGRADATION, UBIQUITIN- PROTEASOME-PATHWAY, CYTOPLASM, HYDROLASE, NUCLEUS, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, PHOSPHOPROTEIN, ZYMOGEN 
3e47:A    (VAL35) to   (THR225)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:C    (THR35) to   (LEU224)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:D    (SER35) to   (ASN226)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:G    (ASN34) to   (SER225)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:H    (GLY11) to   (ASN195)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:K     (THR1) to   (ASP191)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:O    (VAL35) to   (THR225)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:Q    (THR35) to   (LEU224)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:R    (SER35) to   (ASN226)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:U    (ASN34) to   (SER225)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:V    (GLY11) to   (ASN195)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
3e47:Y     (THR1) to   (ASP191)  CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C  |   PROTEASOME, UBIQUITIN, PROTEIN DEGRADATION, INHIBITOR, IMMUNOLOGY, CYTOPLASM, HYDROLASE, NUCLEUS, PHOSPHOPROTEIN, PROTEASE, THREONINE PROTEASE, UBL CONJUGATION, ZYMOGEN 
4eu2:A    (ILE40) to   (ALA238)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:B    (VAL32) to   (SER240)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:C    (GLY33) to   (ILE229)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:D    (THR31) to   (LEU224)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:E    (SER35) to   (ASN233)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:G    (THR34) to   (VAL230)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:L     (THR1) to   (ASP192)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:M     (GLY1) to   (GLU209)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:O    (ILE40) to   (THR235)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:P    (VAL32) to   (SER240)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:Q    (GLY33) to   (ILE229)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:R    (THR31) to   (LEU224)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:S    (SER35) to   (ASN233)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:W     (THR1) to   (ASN194)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
4eu2:Z     (THR1) to   (ASP192)  CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174  |   PROTEASOME INHIBITOR, HYDROLASE-HYDROLASE INHIBITOR COMPLEX 
5jhr:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhr:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhr:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhr:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhr:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhr:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhr:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhr:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhr:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhr:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhr:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhr:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhr:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:G    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:U    (ILE31) to   (ALA229)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5jhs:Y     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
4fzc:A    (VAL32) to   (LYS237)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:B    (GLY32) to   (ILE228)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:C    (THR29) to   (LEU222)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:D    (SER27) to   (ASN225)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:F    (THR31) to   (GLY229)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:G    (ASN30) to   (SER228)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:H     (THR1) to   (ASN194)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:K     (THR1) to   (ASP192)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:O    (VAL32) to   (LYS237)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:P    (GLY32) to   (ILE228)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:Q    (THR29) to   (LEU222)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:R    (SER27) to   (ASN225)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:T    (THR31) to   (GLY229)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:U    (ASN30) to   (SER228)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:V     (THR1) to   (ASN194)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4fzc:Y     (THR1) to   (ASP192)  20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I  |   UBIQUITIN, PROTEASOME, DRUG DEVELOPMENT, INHIBITOR, NATURAL PRODUCT, N-TERMINAL NUCLEOPHILIC HYDROLASE, PROTEIN DEGRADATION, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
4g4s:A    (ILE40) to   (ALA238)  STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX  |   ALPHA BETA, NTN-HYDROLASE, PEPTIDE BINDING, HYDROLASE-CHAPERONE COMPLEX 
4g4s:C    (GLY33) to   (ILE229)  STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX  |   ALPHA BETA, NTN-HYDROLASE, PEPTIDE BINDING, HYDROLASE-CHAPERONE COMPLEX 
4g4s:D    (THR31) to   (LEU224)  STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX  |   ALPHA BETA, NTN-HYDROLASE, PEPTIDE BINDING, HYDROLASE-CHAPERONE COMPLEX 
4g4s:I    (VAL12) to   (ASN194)  STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX  |   ALPHA BETA, NTN-HYDROLASE, PEPTIDE BINDING, HYDROLASE-CHAPERONE COMPLEX 
4g4s:L     (THR1) to   (VAL193)  STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX  |   ALPHA BETA, NTN-HYDROLASE, PEPTIDE BINDING, HYDROLASE-CHAPERONE COMPLEX 
5l52:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:B    (THR33) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:H    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:P    (THR33) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:V    (VAL12) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l52:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:C    (THR29) to   (SER224)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:K     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:Q    (THR29) to   (SER224)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l54:Y     (THR1) to   (VAL193)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:F    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:K     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:T    (THR31) to   (GLY229)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l55:Y     (THR1) to   (ASP192)  YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, INHIBITOR, BINDING ANALYSIS 
5l5a:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:F    (THR31) to   (VAL227)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:K    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5a:Y    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:F    (THR31) to   (VAL227)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:K    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5b:Y    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)  |   HYDROLASE COMPLEX, PROTEASOME, MUTANT, BINDING ANALYSIS, HYDROLASE- HYDROLASE INHIBITOR COMPLEX 
5l5d:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:K    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5d:Y    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:B    (THR33) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:F    (THR31) to   (VAL227)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:K    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:P    (THR33) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5h:Y    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:B    (THR33) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:K    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5i:Y    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:F    (THR31) to   (VAL227)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:K    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5j:Y    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:B    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:F    (THR31) to   (VAL227)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:K    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:P    (GLY32) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5o:Y    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:B    (THR33) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:F    (THR31) to   (VAL227)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:K    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:P    (THR33) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5p:Y    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:B    (THR33) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:F    (THR31) to   (VAL227)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:K    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:P    (THR33) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5q:Y    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:B    (THR33) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:F    (THR31) to   (VAL227)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:K    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:P    (THR33) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:T    (THR31) to   (VAL227)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5s:Y    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:A    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:B    (THR33) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:C    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:D    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:G    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:H     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:K    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:O    (VAL32) to   (THR239)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:P    (THR33) to   (ILE228)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:Q    (THR29) to   (LEU222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:R    (SER27) to   (ILE222)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:U    (ILE31) to   (THR226)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:V     (THR1) to   (ASN194)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5u:Y    (VAL12) to   (ASP191)  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5v:A    (VAL32) to   (THR239)  'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5v:B    (THR33) to   (ILE228)  'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5v:C    (THR29) to   (LEU222)  'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5v:D    (SER27) to   (ILE222)  'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5v:F    (THR31) to   (VAL227)  'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5v:G    (ILE31) to   (THR226)  'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5v:H     (THR1) to   (ASN194)  'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5v:K    (VAL12) to   (ASP191)  'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5v:O    (VAL32) to   (THR239)  'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5v:P    (THR33) to   (ILE228)  'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5v:Q    (THR29) to   (LEU222)  'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5v:R    (SER27) to   (ILE222)  'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5v:T    (THR31) to   (VAL227)  'YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18  |   HYDROLASE-HYDROLASE INHIBITOR COMPLEX, PROTEASOME, MUTANT, INHIBITOR, BINDING ANALYSIS 
5l5v:U